<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jats-oasis2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">mBio</journal-id><journal-id journal-id-type="iso-abbrev">mBio</journal-id><journal-id journal-id-type="publisher-id">mbio</journal-id><journal-title-group><journal-title>mBio</journal-title></journal-title-group><issn pub-type="epub">2150-7511</issn><publisher><publisher-name>American Society for Microbiology</publisher-name><publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8749412</article-id><article-id pub-id-type="pmid">35012352</article-id><article-id pub-id-type="publisher-id">02826-21</article-id><article-id pub-id-type="doi">10.1128/mbio.02826-21</article-id><article-id pub-id-type="publisher-id">mbio.02826-21</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="biological-terms"><compound-subject><compound-subject-part content-type="code">antimicrobial-chemotherapy</compound-subject-part><compound-subject-part content-type="label">Antimicrobial Chemotherapy</compound-subject-part></compound-subject></subj-group></article-categories><title-group><article-title>The Odilorhabdin Antibiotic Biosynthetic Cluster and Acetyltransferase Self-Resistance Locus Are Niche and Species Specific</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lanois-Nouri</surname><given-names>Anne</given-names></name><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><!--<xref ref-type="other" rid="cr1 cr2 cr3 cr4 cr5 cr6 cr7 cr8 cr9 cr10"/>--></contrib><contrib contrib-type="author"><name><surname>Pantel</surname><given-names>Lucile</given-names></name><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref><!--<xref ref-type="other" rid="cr11 cr12 cr13 cr14"/>--></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5120-4674</contrib-id><name><surname>Fu</surname><given-names>Jun</given-names></name><xref rid="aff3" ref-type="aff">
<sup>c</sup>
</xref><!--<xref ref-type="other" rid="cr15 cr16"/>--></contrib><contrib contrib-type="author"><name><surname>Houard</surname><given-names>Jessica</given-names></name><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref><!--<xref ref-type="other" rid="cr17 cr18"/>--></contrib><contrib contrib-type="author"><name><surname>Ogier</surname><given-names>Jean-Claude</given-names></name><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><!--<xref ref-type="other" rid="cr19 cr20 cr21 cr22 cr23 cr24 cr25"/>--></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5064-0327</contrib-id><name><surname>Polikanov</surname><given-names>Yury S.</given-names></name><xref rid="aff4" ref-type="aff">
<sup>d</sup>
</xref><xref rid="aff5" ref-type="aff">
<sup>e</sup>
</xref><!--<xref ref-type="other" rid="cr26 cr27 cr28 cr29"/>--></contrib><contrib contrib-type="author"><name><surname>Racine</surname><given-names>Emilie</given-names></name><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref><!--<xref ref-type="other" rid="cr30 cr31"/>--></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Hailong</given-names></name><xref rid="aff3" ref-type="aff">
<sup>c</sup>
</xref><!--<xref ref-type="other" rid="cr32"/>--></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2789-4959</contrib-id><name><surname>Gaudriault</surname><given-names>Sophie</given-names></name><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><!--<xref ref-type="other" rid="cr33 cr34 cr35 cr36 cr37 cr38 cr39 cr40 cr41"/>--></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3901-5133</contrib-id><name><surname>Givaudan</surname><given-names>Alain</given-names></name><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><email>alain.givaudan@umontpellier.fr</email><!--<xref ref-type="other" rid="cr42 cr43 cr44 cr45 cr46 cr47 cr48 cr49 cr50 cr51 cr52"/>--></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6590-2468</contrib-id><name><surname>Gualtieri</surname><given-names>Maxime</given-names></name><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref><email>m.gualtieri@nosopharm.com</email><!--<xref ref-type="other" rid="cr53 cr54 cr55 cr56 cr57 cr58 cr59 cr60 cr61 cr62 cr63 cr64"/>--></contrib><aff id="aff1">
<label>a</label>
<addr-line>DGIMI, Univ Montpellier, INRAE, Montpellier, France</addr-line>
</aff><aff id="aff2">
<label>b</label>
<addr-line>Nosopharm, N&#x000ee;mes, France</addr-line>
</aff><aff id="aff3">
<label>c</label>
<addr-line>State Key Laboratory of Microbial Technology, Institute of Microbial Technology, Helmholtz International Lab for Anti-infectives, <institution-wrap><institution>Shandong University</institution><institution-id institution-id-type="grid">grid.27255.37</institution-id></institution-wrap>&#x02013;Helmholtz Institute of Biotechnology, Qingdao, Shandong, China</addr-line>
</aff><aff id="aff4">
<label>d</label>
<addr-line>Department of Biological Sciences, University of Illinois at Chicago, Chicago, Illinois, USA</addr-line>
</aff><aff id="aff5">
<label>e</label>
<addr-line>Department of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, Illinois, USA</addr-line>
</aff></contrib-group><contrib-group><contrib contrib-type="editor"><role>Editor</role><name><surname>Bush</surname><given-names>Karen</given-names></name><aff>Indiana University Bloomington</aff></contrib></contrib-group><author-notes><fn fn-type="COI-statement"><p>The authors declare a conflict of interest. M.G. is a founder and shareholder of Nosopharm. L.P., J.H., E.R., and M.G. are employees of Nosopharm.</p></fn></author-notes><pub-date publication-format="electronic" date-type="pub"><day>11</day><month>1</month><year>2022</year></pub-date><pub-date publication-format="electronic" date-type="collection"><season>Jan-Feb</season><year>2022</year></pub-date><pub-date pub-type="pmc-release"><day>11</day><month>1</month><year>2022</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>13</volume><issue>1</issue><elocation-id>e02826-21</elocation-id><history>
<date date-type="received"><day>24</day><month>9</month><year>2021</year></date>
<date date-type="accepted"><day>2</day><month>12</month><year>2021</year></date>
</history><permissions><copyright-statement>Copyright &#x000a9; 2022 Lanois-Nouri et al.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Lanois-Nouri et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-01-11"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="mbio.02826-21.pdf"/><abstract><title>ABSTRACT</title><p>Antibiotic resistance is an increasing threat to human health. A direct link has been established between antimicrobial self-resistance determinants of antibiotic producers, environmental bacteria, and clinical pathogens. Natural odilorhabdins (ODLs) constitute a new family of 10-mer linear cationic peptide antibiotics inhibiting bacterial translation by binding to the 30S subunit of the ribosome. These bioactive secondary metabolites are produced by entomopathogenic bacterial symbiont <italic toggle="yes">Xenorhabdus</italic> (<italic toggle="yes">Morganellaceae</italic>), vectored by the soil-dwelling nematodes. ODL-producing <named-content content-type="genus-species">Xenorhabdus nematophila</named-content> symbionts have mechanisms of self-protection. In this study, we cloned the 44.5-kb <italic toggle="yes">odl</italic> biosynthetic gene cluster (<italic toggle="yes">odl</italic>-BGC) of the symbiont by recombineering and showed that the <italic toggle="yes">N</italic>-acetyltransferase-encoding gene, <italic toggle="yes">oatA</italic>, is responsible for ODL resistance. <italic toggle="yes">In vitro</italic> acetylation and liquid chromatography-tandem mass spectrometry (LC-MS/MS) analyses showed that OatA targeted the side chain amino group of ODL rare amino acids, leading to a loss of translation inhibition and antibacterial properties. Functional, genomic, and phylogenetic analyses of <italic toggle="yes">oatA</italic> revealed an exclusive <italic toggle="yes">cis</italic>-link to the odilorhabdin BGC, found only in <italic toggle="yes">X. nematophila</italic> and a specific phylogenetic clade of <italic toggle="yes">Photorhabdus</italic>. This work highlights the coevolution of antibiotic production and self-resistance as ancient features of this unique tripartite complex of host-vector-symbiont interactions without <italic toggle="yes">odl</italic>-BGC dissemination by lateral gene transfer.</p></abstract><kwd-group><title>KEYWORDS</title><kwd>BGC locus cloning</kwd><kwd>antibiotic resistance</kwd><kwd>genomics and phylogenetic analysis</kwd><kwd>invertebrate-microbe interactions</kwd><kwd>peptide modification</kwd></kwd-group><funding-group specific-use="FundRef"><award-group award-type="grant" id="award1"><funding-source id="GS1">
<institution-wrap><institution>Institut National de la Recherche Agronomique (INRA)</institution><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100006488</institution-id></institution-wrap>
</funding-source><award-id>2013_1333_01 SPE INRA</award-id><award-id>2014_1333 (Innovation)</award-id><principal-award-recipient>
<name><surname>Givaudan</surname><given-names>Alain</given-names></name>
</principal-award-recipient></award-group></funding-group><counts><count count="10" count-type="supplementary-material"/><fig-count count="6"/><table-count count="4"/><equation-count count="0"/><ref-count count="53"/><page-count count="19"/><word-count count="13597"/></counts><custom-meta-group><custom-meta><meta-name>cover-date</meta-name><meta-value>January/February 2022</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>Bioactive natural products and secondary metabolites are a major source of novel antibiotics. Most of the natural drugs identified in the last 40&#x02009;years originate from soil and marine bacteria, such as actinomycetes in particular (<xref rid="B1" ref-type="bibr">1</xref>). Antibacterial products are ancient, and the origins of biosynthetic gene clusters (BGCs) encoding polyketide molecules, such as erythromycin, may date back to 800 million years ago (<xref rid="B2" ref-type="bibr">2</xref>). Logically, antimicrobial resistance may, therefore, be just as ancient.</p><p>Bacteria carrying BGCs encoding antimicrobial agents require protective mechanisms against these compounds (<xref rid="B3" ref-type="bibr">3</xref>), to ensure that their production leads to the destruction of other susceptible microorganisms without causing suicide of the producing bacterium. Over time, a copy of the self-resistance determinant integrates into the BGC, leading to coregulated expression, often through incorporation into the same operon. It has been suggested that horizontal gene transfer (HGT) of entire groups of genes plays a role in the evolution of BGCs and resistance. Over time, bacteria acquire resistance elements reflecting their current and past encounters with antibiotic producers (<xref rid="B4" ref-type="bibr">4</xref>). It has become clear that the environment is the source of an almost unlimited diversity of antibiotic resistance elements that are both extremely specific (e.g., inactivating enzymes) and broad (e.g., efflux systems), enabling the bacterium to counteract most antibiotics. Modification of the antibiotic target is one of the ways in which bacteria protect themselves from the lethal effects of their own antibiotics. <named-content content-type="genus-species">Saccharopolyspora erythraea</named-content>, which produces erythromycin, also produces an enzyme that attaches a methyl group to a specific site on the 23S rRNA, reducing the affinity of ribosomes for this antibiotic (<xref rid="B5" ref-type="bibr">5</xref>). Another mechanism of resistance involves modification of the antibiotic. Some aminoglycoside (AG)-producing actinomycete strains also produce enzymes that inactivate this class of antibiotics by adding phosphate, acetate, or adenylate groups (<xref rid="B6" ref-type="bibr">6</xref>). <named-content content-type="genus-species">Brevibacillus brevis</named-content> uses an <italic toggle="yes">N</italic>-acetyltransferase to modify the antimicrobial peptide edeine (EDE) (<xref rid="B7" ref-type="bibr">7</xref>).</p><p>The entomopathogenic bacteria from the genera <italic toggle="yes">Xenorhabdus</italic> and <italic toggle="yes">Photorhabdus</italic> were formerly assigned to the <italic toggle="yes">Enterobacteriaceae</italic> but have recently been reclassified as members of the <italic toggle="yes">Morganellaceae</italic> (<xref rid="B8" ref-type="bibr">8</xref>). These two genera form tight sister groups, and their members have specific and persistent mutualistic relationships with the infective juveniles (IJs) of soil nematodes (Rhabditida: Steinernematidae and Heterorhabditidae, respectively). These entomopathogenic nematodes (EPNs) cooperate with <italic toggle="yes">Xenorhabdus</italic> and <italic toggle="yes">Photorhabdus</italic> symbionts to kill a broad range of soil-dwelling insect larval hosts (<xref rid="B9" ref-type="bibr">9</xref>). It has been suggested that the ancestors of the symbiotic bacteria of EPNs arose due to ecological events about 375 million years ago and that they provided EPNs with the opportunity to colonize new nematode hosts (<xref rid="B10" ref-type="bibr">10</xref>). <italic toggle="yes">Photorhabdus</italic> and <italic toggle="yes">Xenorhabdus</italic> are both obligate symbionts of EPNs. Indeed, EPN-symbiotic bacteria have never been found living freely in soil, although metagenomics studies have recently detected their presence in a minority microbiota associated with the production of insect larvae (<xref rid="B11" ref-type="bibr">11</xref>). However, <italic toggle="yes">Photorhabdus</italic> has been isolated in a dozen cases of soft tissue abscesses and disseminated bacteremia in humans in the United States and Australia (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>). It has become evident that as long suspected, <italic toggle="yes">Xenorhabdus</italic> and <italic toggle="yes">Photorhabdus</italic> are excellent sources of novel antimicrobial metabolites (<xref rid="B14" ref-type="bibr">14</xref>). EPN-symbiotic bacteria have a complex secondary metabolism characterized by the production of large amounts of specialized secondary metabolites, such as polyketides (PKs) and nonribosomal peptides (NRPs) (<xref rid="B15" ref-type="bibr">15</xref>). Many bioactive metabolites from diverse chemical classes with nematicidal, antifungal, or antibacterial activity have been reported (<xref rid="B16" ref-type="bibr">16</xref>). It has been suggested that the antimicrobial compounds produced by EPN-symbiotic bacteria kill foreign bacterial competitors, to protect the cadavers of the insects in which they multiply from invasion by other microbes (<xref rid="B14" ref-type="bibr">14</xref>). Two novel lead compounds from EPN-symbiotic bacteria are currently in pipelines for the development of novel classes of antibiotics for treating multidrug-resistant Gram-negative bacterial infections (<xref rid="B17" ref-type="bibr">17</xref>). The first of these classes is the odilorhabdins (ODLs), NRP secondary metabolites from <italic toggle="yes">Xenorhabdus</italic> (<xref rid="B18" ref-type="bibr">18</xref>). The second corresponds to darobactin A, a natural product discovered by screening <italic toggle="yes">Photorhabdus</italic> symbionts directly targeting an integral outer membrane protein (<xref rid="B19" ref-type="bibr">19</xref>). ODLs, the first-in-class antibiotics, were discovered, as part of a program aiming to renew the therapeutic antibacterial arsenal, by screening a collection of <italic toggle="yes">Xenorhabdus</italic> species for antimicrobial activity (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B20" ref-type="bibr">20</xref>). NOSO-95A, -B, and -C, natural ODLs, were isolated from <named-content content-type="genus-species">Xenorhabdus nematophila</named-content> K102 (<xref rid="B18" ref-type="bibr">18</xref>). They are 10-mer linear cationic peptides containing six proteinogenic and four to six nonproteinogenic amino acids (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1A</xref>), with promising broad-spectrum activity against both Gram-positive and Gram-negative bacteria, including carbapenem-resistant <italic toggle="yes">Enterobacteriaceae</italic> (CRE) and methicillin-resistant <named-content content-type="genus-species">Staphylococcus aureus</named-content> (MRSA) (<xref rid="B21" ref-type="bibr">21</xref>). Efforts to develop this new antimicrobial class have been pursued: NOSO-502 is the first candidate from the ODL family to undergo preclinical development for the treatment of multidrug-resistant <italic toggle="yes">Enterobacteriaceae</italic> infections (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>). The members of the ODL family have bactericidal action through the specific inhibition of bacterial translation resulting from their interaction with the 30S ribosomal subunit at a site not exploited by other clinically useful antibiotics. They bind to the ribosome in the vicinity of the decoding center (DC), interacting simultaneously with the nucleotides of the 16S rRNA and the anticodon loop of the incoming A-site aminoacyl-tRNA. At low concentrations, ODLs cause the misincorporation of amino acids by decreasing decoding fidelity, whereas at high concentrations, they interfere with the progression of the ribosome along the mRNA. The ability of ODLs to cause miscoding is probably responsible for their bactericidal activity (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B24" ref-type="bibr">24</xref>). As expected, given that ODLs contain nonproteinogenic amino acids synthesized by nonribosomal peptide synthetases (NRPSs), the putative BGC contains four large NRPS-encoding genes (<italic toggle="yes">odl1</italic>, <italic toggle="yes">odl2</italic>, <italic toggle="yes">odl3</italic>, and <italic toggle="yes">odl4</italic>) (<xref rid="B18" ref-type="bibr">18</xref>). Only a few mutant bacteria resistant to ODLs have been reported to date. For example, the His56Tyr variant of the ribosomal protein S10 confers a high degree of resistance to ODLs and has been identified in <named-content content-type="genus-species">Escherichia coli</named-content> (<xref rid="B18" ref-type="bibr">18</xref>). The S10 gene is located close to the 16S rRNA gene. A similar resistance profile was observed for <named-content content-type="genus-species">Klebsiella pneumoniae</named-content> strains bearing mutations affecting the CrrAB two-component system (TCS) (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B25" ref-type="bibr">25</xref>). CrrB mutations cause NOSO-502 resistance by upregulating the KexD efflux pump. This system is also known to decrease colistin sensitivity (<xref rid="B25" ref-type="bibr">25</xref>).</p><fig position="float" id="fig1"><label>FIG&#x000a0;1</label><caption><p>NOSO-95C structure (A), recombineering construction of the <italic toggle="yes">X. nematophila odl</italic>-BGC locus (B), and complementation in <italic toggle="yes">Xenorhabdus</italic> mutants (C and D). (A) Chemical structure of NOSO-95C. <sc>l</sc>-Lysine (Lys<sub>1</sub>, Lys<sub>8</sub>, and Lys<sub>10</sub>) (2<italic toggle="yes">S</italic>,3<italic toggle="yes">S</italic>)-&#x003b1;,&#x003b3;-diamino &#x003b2;-hydroxybutyric acid [Dab(&#x003b2;OH)<sub>2</sub>], (2<italic toggle="yes">S</italic>,3<italic toggle="yes">S</italic>)-&#x003b1;,&#x003b3;-2,4-diamino &#x003b2;-hydroxybutyric acid [Dab(&#x003b2;OH)<sub>3</sub>], glycine (Gly<sub>4</sub>), <sc>d</sc>-ornithine (Orn<sub>5</sub>), proline (Pro<sub>6</sub>), histidine (His<sub>7</sub>), Z-&#x003b1;,&#x003b2;-dehydroarginine (Dha<sub>9</sub>), and a functionalized secondary amide at the C-terminal position (&#x003b1;,&#x003b4;-diamino butane [Dbt<sub>11</sub>]) are shown. (B) Recombineering construction of the <italic toggle="yes">odl</italic>-BGC locus. Three-step recombineering construction of p15A-P<italic toggle="yes"><sub>tet</sub></italic>-<italic toggle="yes">odl</italic>-BGC-mob is shown. Linear-plus-linear homologous recombination (LLHR) between the 44.5-kb <italic toggle="yes">odl</italic>-BGC fragment and the p15A origin vector generated p15A-<italic toggle="yes">odl</italic>-BGC. A first linear-plus-circular homologous recombination (LCHR1) between the Km<sup>r</sup>-Tet<sup>r</sup>-P<sub>LtetO1</sub> fragment and the p15A-<italic toggle="yes">odl</italic>-BGC plasmid generated p15A-P<italic toggle="yes"><sub>tet</sub></italic>-<italic toggle="yes">odl</italic>-BGC containing the 44.5-kb <italic toggle="yes">odl</italic>-BGC fragment under the control of the P<sub>LtetO1</sub> promoter. Finally, a second linear-plus-circular homologous recombination (LCHR2) between the Gm<sup>r</sup>-<italic toggle="yes">mob</italic> fragment and the p15A-P<italic toggle="yes"><sub>tet</sub></italic>-<italic toggle="yes">odl</italic>-BGC plasmid generated the mobilizable plasmid p15A-P<italic toggle="yes"><sub>tet</sub></italic>-<italic toggle="yes">odl</italic>-BGC-mob. Complementation was done in <italic toggle="yes">Xenorhabdus</italic> mutants. (C) Global antimicrobial activities against <named-content content-type="genus-species">Klebsiella pneumoniae</named-content> ATCC 43816 as a target of strains harboring the <italic toggle="yes">odl</italic>-BGC locus. After 24 h at 37&#x000b0;C, zones of growth inhibition were observed. (D) Production and LC-MS analysis of secondary metabolites (Xcn 1, xenocoumacin 1; ODLs, odilorhabdins) in complemented strains (<xref rid="figS1" ref-type="supplementary-material">Fig.&#x000a0;S1</xref>) at 210&#x02009;nm.</p></caption><graphic xlink:href="mbio.02826-21-f001" position="anchor"/></fig><supplementary-material position="float" id="figS1" content-type="local-data"><object-id pub-id-type="doi">10.1128/mBio.02826-21.1</object-id><label>FIG&#x000a0;S1</label><p>LC-MS analysis of <italic toggle="yes">X. nematophila</italic> wild type (WT), mutants, and complemented strains for the production of odilorhabdins (NOSO-95A, -B, and -C) and xenocoumacin. Supernatants from 96-h cultures (or 78-h cultures from complemented strains) were filtered through 0.2-&#x003bc;m filters and analyzed as previously described in Materials and Methods in the main text by LC-MS at 210 nm with molecular masses from 630 to 650 (for ODLs) and from 465 to 467 (for Xcn 1) after extracted ion chromatographic (EIC) analysis. Download <inline-supplementary-material id="fS1" xlink:href="mbio.02826-21-sf001.pdf" content-type="local-data">FIG&#x000a0;S1, PDF file, 1.2 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2022 Lanois-Nouri et al.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Lanois-Nouri et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-01-11"/><license license-type="open-access"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="version-of-record">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material><p>We show here that ODL-producing <italic toggle="yes">X. nematophila</italic> strains display high levels of resistance to their own ODL antibiotic. We investigated the mechanism of self-resistance by cloning the <italic toggle="yes">odl</italic>-BGC. We also assessed the possible involvement of genes flanking this cluster in resistance. A Gcn5-related <italic toggle="yes">N</italic>-acetyltransferase (GNAT)-encoding gene, <italic toggle="yes">oatA</italic>, was identified as responsible for resistance. <italic toggle="yes">In vitro</italic> acetylation and liquid chromatography-tandem mass spectrometry (LC-MS/MS) analyses were performed to identify the target of the enzyme. Multiacetylated forms of NOSO-95C lost their antibacterial activity and were unable to inhibit translation in an <italic toggle="yes">in vitro</italic> translation assay, revealing the molecular mechanism of self-resistance. A molecular study of the distribution of <italic toggle="yes">oatA</italic> revealed that this self-resistance gene was <italic toggle="yes">cis</italic>-linked to the odilorhabdin BGC and found only in <italic toggle="yes">X. nematophila</italic> and a single phylogenetic clade of <italic toggle="yes">Photorhabdus</italic> formerly classified as the species <named-content content-type="genus-species">Photorhabdus luminescens</named-content>.</p></sec><sec id="s2"><title>RESULTS AND DISCUSSION</title><sec id="s2-1"><title>Self-resistance of the odilorhabdin-producing strain <named-content content-type="genus-species">Xenorhabdus nematophila</named-content> K102.</title><p>The supernatants of 80 cultured strains of various <italic toggle="yes">Xenorhabdus</italic> species were screened for the presence of antibacterial activity (<xref rid="B18" ref-type="bibr">18</xref>). Three antibacterial metabolites were characterized from <italic toggle="yes">X. nematophila</italic> strain K102 (CNCM I-4530): NOSO-95A (MW: 1,296&#x02009;Da), NOSO-95B (MW: 1,280&#x02009;Da), and NOSO-95C (MW: 1,264&#x02009;Da) (<xref rid="B18" ref-type="bibr">18</xref>). These compounds have similar structures, differing only by the presence of one or two hydroxylysines in place of the lysine residues in positions 8 and 10 (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1A</xref>). NOSO-95C was the first of these compounds for which total chemical synthesis was completed, and this compound was, therefore, chosen for this study. It was active against a range of clinically relevant Gram-negative bacteria, with a MIC&#x02009;of &#x02264;8&#x02009;&#x003bc;g/mL (<xref rid="tab1" ref-type="table">Table&#x000a0;1</xref>). Interestingly, NOSO-95C was less active against some members of the <italic toggle="yes">Morganellaceae</italic> family, such as <named-content content-type="genus-species">Providencia stuartii</named-content> ATCC 29914 and <named-content content-type="genus-species">Proteus mirabilis</named-content> ATCC 29906, with MICs of 16&#x02009;&#x003bc;g/mL and 32&#x02009;&#x003bc;g/mL, respectively, and was inactive against other members of this family, such as <named-content content-type="genus-species">Morganella morganii</named-content> DSM 30164 and the ODL-producing strain <italic toggle="yes">X. nematophila</italic> K102, with a MIC&#x02009;of &#x0003e;2,048&#x02009;&#x003bc;g/mL, confirming that ODL producers develop mechanisms of self-resistance to ODLs (<xref rid="tab1" ref-type="table">Table&#x000a0;1</xref>).</p><table-wrap position="float" id="tab1"><label>TABLE&#x000a0;1</label><caption><p>MICs of NOSO-95C against a panel of Gram-negative species<xref rid="ngtab1-1" ref-type="table-fn"><sup><italic toggle="yes">a</italic></sup></xref></p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1">Strain</th><th rowspan="1" colspan="1">Family</th><th rowspan="1" colspan="1">MIC of NOSO-95C (&#x003bc;g/mL)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><named-content content-type="genus-species">Escherichia coli</named-content> ATCC 25922</td><td rowspan="1" colspan="1">
<italic toggle="yes">Enterobacteriaceae</italic>
</td><td rowspan="1" colspan="1">8</td></tr><tr><td rowspan="1" colspan="1"><named-content content-type="genus-species">Klebsiella pneumoniae</named-content> NC 09633</td><td rowspan="1" colspan="1">
<italic toggle="yes">Enterobacteriaceae</italic>
</td><td rowspan="1" colspan="1">8</td></tr><tr><td rowspan="1" colspan="1"><named-content content-type="genus-species">Klebsiella aerogenes</named-content> DSM 30053</td><td rowspan="1" colspan="1">
<italic toggle="yes">Enterobacteriaceae</italic>
</td><td rowspan="1" colspan="1">4</td></tr><tr><td rowspan="1" colspan="1"><named-content content-type="genus-species">Enterobacter cloacae</named-content> DSM 14563</td><td rowspan="1" colspan="1">
<italic toggle="yes">Enterobacteriaceae</italic>
</td><td rowspan="1" colspan="1">4</td></tr><tr><td rowspan="1" colspan="1"><named-content content-type="genus-species">Citrobacter freundii</named-content> DSM 30039</td><td rowspan="1" colspan="1">
<italic toggle="yes">Enterobacteriaceae</italic>
</td><td rowspan="1" colspan="1">4</td></tr><tr><td rowspan="1" colspan="1"><named-content content-type="genus-species">Serratia marcescens</named-content> DSM 17174</td><td rowspan="1" colspan="1">
<italic toggle="yes">Enterobacteriaceae</italic>
</td><td rowspan="1" colspan="1">8</td></tr><tr><td rowspan="1" colspan="1"><named-content content-type="genus-species">Pseudomonas aeruginosa</named-content> DSM 1117</td><td rowspan="1" colspan="1">
<italic toggle="yes">Pseudomonadaceae</italic>
</td><td rowspan="1" colspan="1">8</td></tr><tr><td rowspan="1" colspan="1"><named-content content-type="genus-species">Acinetobacter baumannii</named-content> ATCC 19606</td><td rowspan="1" colspan="1">
<italic toggle="yes">Moraxellaceae</italic>
</td><td rowspan="1" colspan="1">8</td></tr><tr><td rowspan="1" colspan="1"><named-content content-type="genus-species">Proteus mirabilis</named-content> ATCC 29906</td><td rowspan="1" colspan="1">
<italic toggle="yes">Morganellaceae</italic>
</td><td rowspan="1" colspan="1">32</td></tr><tr><td rowspan="1" colspan="1"><named-content content-type="genus-species">Providencia stuartii</named-content> ATCC 29914</td><td rowspan="1" colspan="1">
<italic toggle="yes">Morganellaceae</italic>
</td><td rowspan="1" colspan="1">16</td></tr><tr><td rowspan="1" colspan="1"><named-content content-type="genus-species">Morganella morganii</named-content> DSM 30164</td><td rowspan="1" colspan="1">
<italic toggle="yes">Morganellaceae</italic>
</td><td rowspan="1" colspan="1">&#x0003e;2,048</td></tr><tr><td rowspan="1" colspan="1"><named-content content-type="genus-species">Xenorhabdus nematophila</named-content> K102 (CNCM I-4530)</td><td rowspan="1" colspan="1">
<italic toggle="yes">Morganellaceae</italic>
</td><td rowspan="1" colspan="1">&#x0003e;2,048</td></tr></tbody></table><graphic xlink:href="mbio.02826-21-t001" position="anchor"/></alternatives><table-wrap-foot><fn fn-type="other" id="ngtab1-1"><label>a</label><p>MICs were determined according to CLSI guidelines.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-2"><title>Identification of a 44.5-kb locus in <italic toggle="yes">X. nematophila</italic> carrying a BGC encoding odilorhabdins.</title><p>Bioinformatic prediction and the inactivation of an NRPS gene (<xref rid="B24" ref-type="bibr">24</xref>) led to a 32.5-kb BGC locus encompassing <italic toggle="yes">odl1</italic> to <italic toggle="yes">odl4</italic> being considered to encode native odilorhabdin products. This cluster consists of four giant NRPS-encoding genes in the genomic sequence of <italic toggle="yes">X. nematophila</italic> (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1B</xref>). One challenging way to demonstrate that the complete set of genes embedded within a cluster is required for the biosynthesis of a particular metabolite is to insert the BGC locus into a heterologous host. Considerable amounts of genomic data are available for EPN-symbiotic bacteria, which have unexplored pathways of secondary metabolism (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>). Optimized protocols have, therefore, been developed for the efficient cloning of large DNA fragments (<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>). We obtained a mobilizable plasmid carrying genes encoding NRPS putatively required for odilorhabdin synthesis, through a three-step cloning procedure with one linear-linear homologous recombination (LLHR) step and two linear-circular homologous recombination (LCHR) steps involving RecET- and Red&#x003b1;&#x003b2;-based techniques, respectively (<xref rid="B29" ref-type="bibr">29</xref>) (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1B</xref>). The cloned 44.5-kb <italic toggle="yes">odl-</italic>BGC locus from <italic toggle="yes">X. nematophila</italic> under P<italic toggle="yes"><sub>tet</sub></italic> control extended from the start of the <italic toggle="yes">ectB</italic> gene to the end of the following SphI site (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1B</xref>). In <italic toggle="yes">X. nematophila</italic>, xenocoumacin (Xcn) production (&#x00394;<italic toggle="yes">xcnKL</italic> mutant strain) has been shown to be responsible for the principal zone of growth inhibition in the target strain <named-content content-type="genus-species">Micrococcus luteus</named-content>, and the double mutant strain &#x00394;<italic toggle="yes">xcnKL</italic>::<italic toggle="yes">odl1</italic> (previously called &#x00394;<italic toggle="yes">xcnKL</italic>::F) has been shown to display an almost complete loss of this zone of inhibition (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B30" ref-type="bibr">30</xref>). We show here that the complementation of the <italic toggle="yes">X. nematophila</italic> double mutant strain (&#x00394;<italic toggle="yes">xcnKL</italic>::<italic toggle="yes">odl1</italic>) to full functionality through the introduction of a plasmid harboring the <italic toggle="yes">X. nematophila</italic> 44.5-kb <italic toggle="yes">odl-</italic>BGC locus under the control of P<italic toggle="yes"><sub>tet</sub></italic> restored antibacterial activity against <named-content content-type="genus-species">Klebsiella pneumoniae</named-content> (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1C</xref>). In addition, our liquid chromatography coupled to mass spectrometry (LC-MS) analysis revealed the presence of 1,296-Da (NOSO-95A), 1,280-Da (NOSO-95B), and 1,264-Da (NOSO-95C) products in the exconjugants (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1D</xref>; see also <xref rid="figS1" ref-type="supplementary-material">Fig.&#x000a0;S1</xref> in the supplemental material).</p><p>We then introduced the p15A-P<italic toggle="yes"><sub>tet</sub>-odl-</italic>BGC plasmid DNA into an <named-content content-type="genus-species">E. coli</named-content> strain carrying the phosphopantheteinyl transferase (PPTase) gene (<italic toggle="yes">ngrA</italic>) of <italic toggle="yes">X. nematophila</italic> (<xref rid="B30" ref-type="bibr">30</xref>). PPTases posttranslationally modify the modular and iterative synthases acting in a processive fashion: fatty acid synthases (FAS), polyketide synthases (PKS), and NRPS (<xref rid="B31" ref-type="bibr">31</xref>). We assessed antibiotic production under predefined conditions in which <italic toggle="yes">odl</italic> mutant complementation had been obtained. We were able to detect the expression of <italic toggle="yes">ectB</italic> (the first gene of the cloned locus) and <italic toggle="yes">odl1</italic> (the first NRPS gene) by quantitative reverse transcription PCR (RT-qPCR) experiments (<xref rid="figS2" ref-type="supplementary-material">Fig.&#x000a0;S2A</xref>), but no antibiotic activity against <named-content content-type="genus-species">K. pneumoniae</named-content> (<xref rid="figS2" ref-type="supplementary-material">Fig.&#x000a0;S2B</xref>) or odilorhabdin derivatives were detected in the extracts of <named-content content-type="genus-species">E. coli</named-content> transformants by LC-MS profiling (<xref rid="figS1" ref-type="supplementary-material">Fig.&#x000a0;S1</xref> and <xref rid="figS2" ref-type="supplementary-material">S2</xref>C). The cluster encompassing <italic toggle="yes">odl1</italic> to <italic toggle="yes">odl4</italic> from <named-content content-type="genus-species">Photorhabdus laumondii</named-content> TT01 had been cloned in a previous study, but again, no derivative products were detected (<xref rid="B29" ref-type="bibr">29</xref>). The extent to which a pathway is successfully expressed is unpredictable, due to the idiosyncrasies of the different heterologous bacterial hosts, which may not necessarily produce all the necessary precursors (<xref rid="B31" ref-type="bibr">31</xref>). For example, the antibiotic erythromycin C is produced in 10,000 times larger amounts by its native host <italic toggle="yes">S. erythraea</italic> than by the heterologous host <named-content content-type="genus-species">E. coli</named-content> K207-2 (<xref rid="B32" ref-type="bibr">32</xref>). These data suggest that the 44.5-kb <italic toggle="yes">odl</italic> locus may lack modification enzyme genes in <named-content content-type="genus-species">E. coli</named-content>.</p><supplementary-material position="float" id="figS2" content-type="local-data"><object-id pub-id-type="doi">10.1128/mBio.02826-21.2</object-id><label>FIG&#x000a0;S2</label><p>Complementation of <named-content content-type="genus-species">E. coli</named-content> XL1 (pBB-<italic toggle="yes">ngrA</italic>) with p15A-P<italic toggle="yes"><sub>tet</sub></italic>-<italic toggle="yes">odl</italic>-BGC. (A) Expression of <italic toggle="yes">odl</italic>-BGC locus genes in XL1 (pBB-<italic toggle="yes">ngrA</italic>) (p15A-P<italic toggle="yes"><sub>tet</sub></italic>-<italic toggle="yes">odl</italic>-BGC). Total RNA was first extracted from 100-mL broth cultures of XL1 (pBB-<italic toggle="yes">ngrA</italic>) (p15A-P<italic toggle="yes"><sub>tet</sub></italic>-<italic toggle="yes">odl</italic>-BGC) or XL1 (pBB-<italic toggle="yes">ngrA</italic>) (pACYC184) incubated with or without aTc at 28&#x000b0;C for 78 h, as previously described (1). Briefly, RNA was isolated with the RNeasy Protect Bacteria miniprep kit (Qiagen), including DNase I incubation in accordance with the manufacturer&#x02019;s recommendations. For each RNA preparation, we assessed DNA contamination by carrying out a 16S control PCR. The quantity and quality of total RNA were assessed with a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific) and an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent). RT-qPCR was performed in two steps, as previously described (1). First, the cDNA was synthesized from 0.5&#x02009;&#x003bc;g of total RNA with SuperScript II reverse transcriptase from Invitrogen and random hexamers (100 mg/L) from Promega. We then performed qPCR in triplicate with the SensiFAST SYBR <italic toggle="yes">No-ROX</italic> kit (Bioline), with 1&#x02009;&#x003bc;L of cDNA synthesis mixture (diluted 1:50) and 1 &#x003bc;M specific primers for the studied genes (<xref rid="tabS2" ref-type="supplementary-material">Table&#x000a0;S2</xref>). The enzyme was activated by heating for 2 min at 95&#x000b0;C. All qPCRs were performed in three technical replicates, with 45 cycles of 95&#x000b0;C for 5 s and 61&#x000b0;C for 30 s, and were monitored in the LightCycler 480 system (Roche). Melting curves were analyzed for each reaction, and each curve contained a single peak. For standard curves, the amounts of PCR products generated were determined with serially diluted genomic DNA from <italic toggle="yes">X. nematophila</italic> (for <italic toggle="yes">ectB</italic> and <italic toggle="yes">odl1</italic>) or <named-content content-type="genus-species">E. coli</named-content> (for <italic toggle="yes">gyrB</italic>). Histograms represent the relative transcript levels of <italic toggle="yes">ectB</italic> and <italic toggle="yes">odl1</italic> versus the <italic toggle="yes">gyrB</italic> gene used as housekeeping gene, as calculated with LightCycler 480 software (Roche). The data shown are the medians of experimental triplicates, and error bars represent the statistical standard deviations. (B) Global antimicrobial activities against <named-content content-type="genus-species">Klebsiella pneumoniae</named-content> ATCC 43816 as a target of strains harboring <italic toggle="yes">odl</italic>-BGC loci (see Materials and Methods in the main text). (C) Supernatants from cultures used for RNA preparation (see panel A) were passed through a filter with 0.2-&#x003bc;m pores and concentrated 10-fold for LC-MS analysis. Natural odilorhabdins (NOSO-95A, -B, and -C) and xenocoumacin 1 (Xcn 1) were identified in culture supernatants by LC-MS as described in Materials and Methods in the main text (see also <xref rid="figS1" ref-type="supplementary-material">Fig.&#x000a0;S1</xref>). Download <inline-supplementary-material id="fS2" xlink:href="mbio.02826-21-sf002.pdf" content-type="local-data">FIG&#x000a0;S2, PDF file, 0.1 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2022 Lanois-Nouri et al.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Lanois-Nouri et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-01-11"/><license license-type="open-access"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="version-of-record">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material></sec><sec id="s2-3"><title>The <italic toggle="yes">N</italic>-acetyltransferase gene, <italic toggle="yes">oatA</italic>, embedded in the <italic toggle="yes">odl</italic>-BGC is responsible for NOSO-95C self-resistance.</title><p>As expected, the MICs obtained showed that the complete 44.5-kb <italic toggle="yes">odl-</italic>BGC locus of <italic toggle="yes">X. nematophila</italic> expressed under the control of P<italic toggle="yes"><sub>tet</sub></italic> after anhydrotetracycline (aTc) induction encoded NOSO-95C resistance (MIC, 256&#x02009;&#x003bc;g/mL) (<xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>). For identification of the genes responsible for odilorhabdin self-resistance, we also subcloned the genes at the periphery of the <italic toggle="yes">odl</italic>-BGC locus, giving 10 genes in all, in <named-content content-type="genus-species">E. coli</named-content> (<xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>). Only expression of the 2,764-bp DNA fragment containing the three genes upstream from <italic toggle="yes">odl1</italic> resulted in NOSO-95C resistance in the recombinant <named-content content-type="genus-species">E. coli</named-content> strains, and subcloning experiments clearly showed that a single gene, &#x0201c;<italic toggle="yes">c</italic>,&#x0201d; was responsible for resistance to NOSO-95C (MIC, 512&#x02009;&#x003bc;g/mL) after isopropyl-&#x003b2;-<sc>d</sc>-thiogalactoside (IPTG) induction (<xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>). The BLASTP genome annotation and InterPro domain identified the C protein as a Gcn5-related <italic toggle="yes">N</italic>-acetyltransferase (GNAT). We therefore named this gene <italic toggle="yes">oatA</italic>, for odilorhabdin acetyltransferase A. The GNAT family includes more than 100,000 enzymes present in eukaryotes and prokaryotes (<xref rid="B33" ref-type="bibr">33</xref>). These enzymes catalyze the transfer of an acetyl group from acetyl coenzyme A (acetyl-CoA) to a primary amine in diverse acceptor molecules. They are involved in multiple physiological events, including bacterial drug resistance, the regulation of transcription, toxin-antitoxin system control, detoxification, and protection against oxidative stress (<xref rid="B34" ref-type="bibr">34</xref>). Many aminoglycoside (AG) acetyltransferases have since been described and are among the principal sources of clinically relevant aminoglycoside resistance (<xref rid="B35" ref-type="bibr">35</xref>).</p><fig position="float" id="fig2"><label>FIG&#x000a0;2</label><caption><p>Subcloning of odilorhabdin BGC locus and putative ODL resistance genes. Odilorhabdin self-resistance gene identification was done by subcloning of the <italic toggle="yes">odl</italic>-BGC locus of <italic toggle="yes">X. nematophila</italic>. The <italic toggle="yes">odl</italic>-BGC locus of <italic toggle="yes">X. nematophila</italic> cloned into XL1 Blue MRF&#x02032; confers resistance to odilorhabdin. In order to identify the odilorhabdin self-resistance gene, subcloning of the three upstream genes and the seven downstream genes from the <italic toggle="yes">odl</italic>-BGC locus was realized by PCR amplification using appropriate primers into pUC19 vector under the control of the P<italic toggle="yes"><sub>lac</sub></italic> promoter. On the right are MICs of NOSO-95C for XL1 Blue MRF&#x02032; carrying the entire cloned fragment after induction with aTc (200&#x02009;ng/mL) or subcloned genes after induction with IPTG (0.2&#x02009;mM). pACYC184 and pUC19 were used as controls.</p></caption><graphic xlink:href="mbio.02826-21-f002" position="anchor"/></fig></sec><sec id="s2-4"><title>Characterization of <italic toggle="yes">Xenorhabdus</italic> OatA<sub>Xn</sub> and its <italic toggle="yes">N</italic>-acetylated products.</title><p>OatA from <italic toggle="yes">X. nematophila</italic> F1 was first overexpressed in the BL21 system and purified (<xref rid="figS3" ref-type="supplementary-material">Fig.&#x000a0;S3</xref>). We obtained about 2.2&#x02009;mg of OatA::tag His per liter of culture. Assuming that ODLs are the substrates of this enzyme, <italic toggle="yes">in vitro</italic> acetylation experiments were performed to identify the sites acetylated. NOSO-95C was reacted with the purified OatA enzyme in the presence of acetyl-CoA. After incubation for 15 min, LC-MS revealed the presence of a single UV peak at a retention time of 9.71 min with a major associated <italic toggle="yes">m/z</italic>&#x02009;of&#x02009;1,307, consistent with the mass of monoacetylated NOSO-95C (<xref rid="figS4" ref-type="supplementary-material">Fig.&#x000a0;S4A</xref>). After incubation for 4 h or 24 h, we observed two separate UV peaks at retention times of 9.6 min and 10.4 min with associated <italic toggle="yes">m/z</italic>&#x02009;of&#x02009;1,349 and 1,391, respectively, consistent with the masses of biacetylated and triacetylated NOSO-95C. The native compound (<italic toggle="yes">m/z</italic> 1,265) had entirely disappeared. The peak area ratios at 230&#x02009;nm (biacetylated/triacetylated) were 25 and 4.2, respectively, indicating that the biacetylated form remained largely predominant. An autoacetylation control was performed, with NOSO-95C and acetyl-CoA in the absence of enzyme (<xref rid="figS4" ref-type="supplementary-material">Fig.&#x000a0;S4B</xref>). After 15&#x02009;min, 4 h, and 24 h, native unacetylated NOSO-95C was mainly detected, with 100%, 97%, and 72%, respectively, of the compound remaining (<xref rid="figS4" ref-type="supplementary-material">Fig.&#x000a0;S4</xref>).</p><supplementary-material position="float" id="figS3" content-type="local-data"><object-id pub-id-type="doi">10.1128/mBio.02826-21.3</object-id><label>FIG&#x000a0;S3</label><p>SDS-PAGE of His-tagged OatA protein production and purification. We assessed production of the His-tagged OatA protein, by centrifuging 500 mL of a culture of the strain BL21(DE3) (pET-<italic toggle="yes">oatA</italic>) after induction with IPTG and resuspending the pellet in 20 mL of 2&#x000d7; Laemmli sample buffer. The sample was then run on a 15% acrylamide SDS-PAGE gel (2). The BL21(DE3) (pET-28a) strain was used as a control (1). After purification of the His-tagged OatA protein with Ni-NTA agarose, aliquots (10 mL) of 250 mM imidazole (3) and 500 mM imidazole (4) eluates were also run on a 15% acrylamide SDS-PAGE gel with the PageRuler Plus prestained protein ladder (Thermo Fisher Scientific) (M). After electrophoresis at 150 V (3 W) for 5 h, the acrylamide gel was stained overnight in a solution containing 0.1% Coomassie Blue with ethanol-acetic acid (40% to 10%) and destained in ethanol-acetic acid (40% to 10%) for 3 h before the gel was scanned. Download <inline-supplementary-material id="fS3" xlink:href="mbio.02826-21-sf003.pdf" content-type="local-data">FIG&#x000a0;S3, PDF file, 0.3 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2022 Lanois-Nouri et al.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Lanois-Nouri et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-01-11"/><license license-type="open-access"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="version-of-record">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material><supplementary-material position="float" id="figS4" content-type="local-data"><object-id pub-id-type="doi">10.1128/mBio.02826-21.4</object-id><label>FIG&#x000a0;S4</label><p>LC-MS analysis of NOSO-95C and acetylated derivatives after <italic toggle="yes">in vitro</italic> acetylation (see Materials and Methods in the main text) at different times of reaction (15 min, 4 h, or 24 h) with acetyl-CoA (B), odilorhabdin acetyltransferase A (OatA) (C), or both (A). For each tested condition, a table and corresponding LC-MS chromatograms present observed ions with retention time, peak area, and suggested compounds. LC-MS was performed on an Agilent 1260 Infinity HPLC system with a Waters Symmetry analytical C<sub>18</sub> column (5 &#x003bc;m, 4.6 mm&#x02009;by&#x02009;150 mm). We injected 10 &#x003bc;L of reaction mixture into the apparatus, the flow rate was set to 0.7 mL/min, and UV detection was performed at 220, 230, and 250 nm. The following mobile phases were used: A, 0.1% trifluoroacetic acid in water; B, acetonitrile. The following gradient was used: 2 to 30% of mobile phase B in mobile phase A from 0 to 15 min. ESI-LC-MS data were obtained in positive mode on an Agilent 1260 Infinity system (Agilent 6120 quadrupole LC/MS, 1260 quaternary pump, 1260 ALS, 1260 TCC, 1260 DAD VL, 1260 FC-AS). Download <inline-supplementary-material id="fS4" xlink:href="mbio.02826-21-sf004.pdf" content-type="local-data">FIG&#x000a0;S4, PDF file, 0.6 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2022 Lanois-Nouri et al.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Lanois-Nouri et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-01-11"/><license license-type="open-access"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="version-of-record">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material><p>Whatever the incubation time, reaction mixtures lost antibacterial activity, whereas the controls did not, indicating that the mono-, bi-, and triacetylated forms of NOSO-95C were inactive (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3A</xref>). Previous studies have shown that NOSO-95C interferes with protein synthesis in living bacteria and inhibits the production of green fluorescent protein (GFP) in an <named-content content-type="genus-species">E. coli</named-content> cell-free transcription-translation assay (<xref rid="B18" ref-type="bibr">18</xref>). We performed <italic toggle="yes">in vitro</italic> translation assays to demonstrate that the loss of antibacterial activity in acetylated compounds was due to a loss of their ability to inhibit bacterial translation. Gentamicin, a ribosomal inhibitor, was used as a positive control; it blocked GFP translation, resulting in low levels of fluorescence. Similar inhibition profiles were observed with the unmodified NOSO-95C controls. OatA enzyme alone, without acetyl-CoA, appeared to limit partially the potential of NOSO-95C to inhibit translation. We hypothesized that the enzyme had a strong affinity for NOSO-95C, decreasing the amount of free compound available. The reaction mixtures containing mono-, bi-, and triacetylated NOSO-95C had no effect on GFP translation, resulting in high levels of fluorescence. The acetylated forms of NOSO-95C prevented the inhibition of protein synthesis, probably by blocking ribosome binding (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3B</xref>).</p><fig position="float" id="fig3"><label>FIG&#x000a0;3</label><caption><p>Characterization of acetylated NOSO-95C. (A) Antibacterial activity against <named-content content-type="genus-species">E. coli</named-content> ATCC 25922 of NOSO-95C after various reaction times (15&#x02009;min, 4 h, or 24 h) with acetyl-CoA (2), odilorhabdin acetyltransferase (OatA) (3), or both (4). OatA with acetyl-CoA was used as a negative control (1). (B) Inhibition of synthesis of the GFP reporter protein in the <named-content content-type="genus-species">E. coli</named-content> cell-free transcription-translation system by NOSO-95C after various reaction times (15&#x02009;min, 4 h, or 24 h) with acetyl-CoA, OatA, or both. OatA with acetyl-CoA was used as a negative control. Gentamicin (10&#x02009;&#x003bc;M) was used as a positive control. The data shown are the means of three experiments &#x000b1; SD.</p></caption><graphic xlink:href="mbio.02826-21-f003" position="anchor"/></fig></sec><sec id="s2-5"><title>Structural analysis of monoacetylated, biacetylated, and triacetylated NOSO-95C.</title><p>OatA belongs to the GNAT superfamily, a group of enzymes catalyzing the transfer of an acetyl group from acetyl-CoA to a primary amine in diverse acceptor molecules. NOSO-95C contains eight primary amino groups (&#x003b5;- and &#x003b1;-primary amines of lysine in position 1), Dab(&#x003b2;OH) in positions 2 and 3, <sc>d</sc>-Orn in position 5, <sc>l</sc>-Lys in positions 8 and 10, and Dbt at the C-terminal position, all of which are possible sites of <italic toggle="yes">N</italic>-acetylation by OatA. The location of the acetyl groups was assessed by LC-MS/MS fragmentation analyses comparing monoacetylated, biacetylated, and triacetylated NOSO-95C with native NOSO-95C (<xref rid="figS5" ref-type="supplementary-material">Fig.&#x000a0;S5</xref>). The presence of an additional acetyl group adds 42&#x02009;Da to the initial molecular weight. The fragmentation spectrum of NOSO-95C (<italic toggle="yes">m/z</italic> 1,265) was first generated, to identify characteristic fragment ions (<xref rid="tab2" ref-type="table">Table&#x000a0;2</xref>). For monoacetylated NOSO-95C (<italic toggle="yes">m/z</italic> 1,307), ion fragments with <italic toggle="yes">m/z</italic> of 1,178 and 1,020.6 were obtained by the elimination of 129&#x02009;Da and 287&#x02009;Da, respectively, consistent with the loss of Lys<sub>1</sub> and Lys<sub>1</sub>-acetylated Dab(&#x003b2;OH)<sub>2</sub> (<xref rid="tab2" ref-type="table">Table&#x000a0;2</xref>). The fragmentation spectrum of biacetylated NOSO-95C (<italic toggle="yes">m/z</italic> 1,349) revealed ion fragments with <italic toggle="yes">m/z</italic> of 1,220.7, 1,062.6, and 904.6 obtained by the elimination of 129&#x02009;Da, 287&#x02009;Da, and 445&#x02009;Da, respectively, consistent with the loss of Lys<sub>1</sub>, Lys<sub>1</sub>-acetylated Dab(&#x003b2;OH)<sub>2</sub>, and Lys<sub>1</sub>-acetylated Dab(&#x003b2;OH)<sub>2</sub>-acetylated Dab(&#x003b2;OH)<sub>3</sub> (<xref rid="tab2" ref-type="table">Table&#x000a0;2</xref>). The fragmentation profiles of mono- and biacetylated NOSO-95C therefore revealed structures with acetyl groups located on the amino groups of the Dab(&#x003b2;OH) residues. For the triacetylated NOSO-95C (<italic toggle="yes">m/z</italic> 1,391), a fragmentation pattern similar to that for biacetylated NOSO-95C was obtained, with the loss of 129&#x02009;Da, 287&#x02009;Da, and 445&#x02009;Da, indicating that Dab(&#x003b2;OH)<sub>2</sub> and Dab(&#x003b2;OH)<sub>3</sub> were acetylated. A difference of 258&#x02009;Da between <italic toggle="yes">m/z</italic> 1,391 and <italic toggle="yes">m/z</italic> 1,132.6 was assigned to the loss of Lys<sub>10</sub> and Dbt<sub>11</sub>, with an acetyl group. Fragment ions with <italic toggle="yes">m/z</italic> of 1,174.6 and 687.4 were useful for determining which of these two amino acids were acetylated. These fragment ions are generated by the elimination of a nonmodified Dbt<sub>11</sub> (88&#x02009;Da), making it possible to conclude that the last acetyl group is located on the primary amino group of Lys<sub>10</sub> (<xref rid="tab2" ref-type="table">Table&#x000a0;2</xref>).</p><table-wrap position="float" id="tab2"><label>TABLE&#x000a0;2</label><caption><p>MS/MS fragmentation analysis of acetylated odilorhabdin NOSO-95C<xref rid="ngtab2-1" ref-type="table-fn"><sup><italic toggle="yes">a</italic></sup></xref></p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1">NOSO-95C form and ion</th><th rowspan="1" colspan="1">
<italic toggle="yes">m/z</italic>
</th><th rowspan="1" colspan="1">Neutral loss from previous ion</th><th rowspan="1" colspan="1">Attribution</th><th rowspan="1" colspan="1">Assigned structure</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">NOSO-95C (<italic toggle="yes">m/z</italic> 1,265)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;[M&#x02009;+&#x02009;2H]2+</td><td rowspan="1" colspan="1">633</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lys-Dab(&#x003b2;OH)-Dab(&#x003b2;OH)-Gly-Orn-Pro-His-Lys-Dha-Lys-Dbt</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;y<sub>10</sub></td><td rowspan="1" colspan="1">1,136.7</td><td rowspan="1" colspan="1">129</td><td rowspan="1" colspan="1">Lys<sub>1</sub></td><td rowspan="1" colspan="1">Dab(&#x003b2;OH)-Dab(&#x003b2;OH)-Gly-Orn-Pro-His-Lys-Dha-Lys-Dbt</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;y<sub>9</sub></td><td rowspan="1" colspan="1">1,020.6</td><td rowspan="1" colspan="1">116</td><td rowspan="1" colspan="1">Dab(&#x003b2;OH)<sub>2</sub></td><td rowspan="1" colspan="1">Dab(&#x003b2;OH)-Gly-Orn-Pro-His-Lys-Dha-Lys-Dbt</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">804.4</td><td rowspan="1" colspan="1">216 (128&#x02009;+&#x02009;88)</td><td rowspan="1" colspan="1">Lys<sub>10</sub>-Dbt<sub>11</sub></td><td rowspan="1" colspan="1">Dab(&#x003b2;OH)-Gly-Orn-Pro-His-Lys-Dha</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;y<sub>8</sub></td><td rowspan="1" colspan="1">904.6</td><td rowspan="1" colspan="1">116</td><td rowspan="1" colspan="1">Dab(&#x003b2;OH)<sub>3</sub></td><td rowspan="1" colspan="1">Gly-Orn-Pro-His-Lys-Dha-Lys-Dbt</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">688.4</td><td rowspan="1" colspan="1">216 (128&#x02009;+&#x02009;88)</td><td rowspan="1" colspan="1">Lys<sub>10</sub>-Dbt<sub>11</sub></td><td rowspan="1" colspan="1">Gly-Orn-Pro-His-Lys-Dha</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;y<sub>6</sub></td><td rowspan="1" colspan="1">733.5</td><td rowspan="1" colspan="1">171</td><td rowspan="1" colspan="1">Gly<sub>4</sub>-Orn<sub>5</sub></td><td rowspan="1" colspan="1">Pro-His-Lys-Dha-Lys-Dbt</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">517.3</td><td rowspan="1" colspan="1">216 (128&#x02009;+&#x02009;88)</td><td rowspan="1" colspan="1">Lys<sub>10</sub>-Dbt<sub>11</sub></td><td rowspan="1" colspan="1">Pro-His-Lys-Dha</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;b<sub>9</sub></td><td rowspan="1" colspan="1">1,048.6</td><td rowspan="1" colspan="1">216 (128&#x02009;+&#x02009;88)</td><td rowspan="1" colspan="1">Lys<sub>10</sub>-Dbt<sub>11</sub></td><td rowspan="1" colspan="1">Lys- Dab(&#x003b2;OH)-Dab(&#x003b2;OH)-Gly-Orn-Pro-His-Lys-Dha</td></tr><tr><td rowspan="1" colspan="1">Monoacetylated NOSO-95C (<italic toggle="yes">m/z</italic> 1,307)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;[M&#x02009;+&#x02009;2H]2+</td><td rowspan="1" colspan="1">654</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Lys-Dab(&#x003b2;OH)-Dab(&#x003b2;OH)-Gly-Orn-Pro-His-Lys-Dha-Lys-Dbt</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;y<sub>10</sub></td><td rowspan="1" colspan="1">1,178</td><td rowspan="1" colspan="1">129</td><td rowspan="1" colspan="1">Lys<sub>1</sub></td><td rowspan="1" colspan="1">AcDab(&#x003b2;OH)-Dab(&#x003b2;OH)-Gly-Orn-Pro-His-Lys-Dha-Lys-Dbt</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;y<sub>9</sub></td><td rowspan="1" colspan="1">1,020.6</td><td rowspan="1" colspan="1">158</td><td rowspan="1" colspan="1">AcDab(&#x003b2;OH)<sub>2</sub></td><td rowspan="1" colspan="1">Dab(&#x003b2;OH)-Gly-Orn-Pro-His-Lys-Dha-Lys-Dbt</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;y<sub>8</sub></td><td rowspan="1" colspan="1">904.6</td><td rowspan="1" colspan="1">116</td><td rowspan="1" colspan="1">Dab(&#x003b2;OH)<sub>3</sub></td><td rowspan="1" colspan="1">Gly-Orn-Pro-His-Lys-Dha-Lys-Dbt</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">688.4</td><td rowspan="1" colspan="1">216 (128&#x02009;+&#x02009;88)</td><td rowspan="1" colspan="1">Lys<sub>10</sub>-Dbt<sub>11</sub></td><td rowspan="1" colspan="1">Gly-Orn-Pro-His-Lys-Dha</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;y<sub>6</sub></td><td rowspan="1" colspan="1">733.5</td><td rowspan="1" colspan="1">171</td><td rowspan="1" colspan="1">Gly<sub>4</sub>-Orn<sub>5</sub></td><td rowspan="1" colspan="1">Pro-His-Lys-Dha-Lys-Dbt</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">517.3</td><td rowspan="1" colspan="1">216 (128&#x02009;+&#x02009;88)</td><td rowspan="1" colspan="1">Lys<sub>10</sub>-Dbt<sub>11</sub></td><td rowspan="1" colspan="1">Pro-His-Lys-Dha</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;y<sub>5</sub></td><td rowspan="1" colspan="1">635.9</td><td rowspan="1" colspan="1">97</td><td rowspan="1" colspan="1">Pro<sub>9</sub></td><td rowspan="1" colspan="1">His-Lys-Dha-Lys-Dbt</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;b<sub>9</sub></td><td rowspan="1" colspan="1">1,090.6</td><td rowspan="1" colspan="1">216 (128&#x02009;+&#x02009;88)</td><td rowspan="1" colspan="1">Lys<sub>10</sub>-Dbt<sub>11</sub></td><td rowspan="1" colspan="1">Lys-AcDab(&#x003b2;OH)-Dab(&#x003b2;OH)-Gly-Orn-Pro-His-Lys-Dha</td></tr><tr><td rowspan="1" colspan="1">Biacetylated NOSO-95C (<italic toggle="yes">m/z</italic> 1,349)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;[M&#x02009;+&#x02009;2H]2+</td><td rowspan="1" colspan="1">675</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;y<sub>10</sub></td><td rowspan="1" colspan="1">1,220.7</td><td rowspan="1" colspan="1">129</td><td rowspan="1" colspan="1">Lys<sub>1</sub></td><td rowspan="1" colspan="1">AcDab(&#x003b2;OH)-AcDab(&#x003b2;OH)-Gly-Orn-Pro-His-Lys-Dha-Lys-Dbt</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;y<sub>9</sub></td><td rowspan="1" colspan="1">1,062.6</td><td rowspan="1" colspan="1">158</td><td rowspan="1" colspan="1">AcDab(&#x003b2;OH)<sub>2</sub></td><td rowspan="1" colspan="1">AcDab(&#x003b2;OH)-Gly-Orn-Pro-His-Lys-Dha-Lys-Dbt</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">846.4</td><td rowspan="1" colspan="1">216 (128&#x02009;+&#x02009;88)</td><td rowspan="1" colspan="1">Lys<sub>10</sub>-Dbt<sub>11</sub></td><td rowspan="1" colspan="1">AcDab(&#x003b2;OH)-Gly-Orn-Pro-His-Lys-Dha</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;y<sub>8</sub></td><td rowspan="1" colspan="1">904.6</td><td rowspan="1" colspan="1">158</td><td rowspan="1" colspan="1">AcDab(&#x003b2;OH)<sub>3</sub></td><td rowspan="1" colspan="1">Gly-Orn-Pro-His-Lys-Dha-Lys-Dbt</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">688.4</td><td rowspan="1" colspan="1">216 (128&#x02009;+&#x02009;88)</td><td rowspan="1" colspan="1">Lys<sub>10</sub>-Dbt<sub>11</sub></td><td rowspan="1" colspan="1">Gly-Orn-Pro-His-Lys-Dha</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;y<sub>6</sub></td><td rowspan="1" colspan="1">733.5</td><td rowspan="1" colspan="1">171</td><td rowspan="1" colspan="1">Gly<sub>4</sub>-Orn<sub>5</sub></td><td rowspan="1" colspan="1">Pro-His-Lys-Dha-Lys-Dbt</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">517.3</td><td rowspan="1" colspan="1">216 (128&#x02009;+&#x02009;88)</td><td rowspan="1" colspan="1">Lys<sub>10</sub>-Dbt<sub>11</sub></td><td rowspan="1" colspan="1">Pro-His-Lys-Dha</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;b<sub>9</sub></td><td rowspan="1" colspan="1">1,132.6</td><td rowspan="1" colspan="1">216 (128&#x02009;+&#x02009;88)</td><td rowspan="1" colspan="1">Lys<sub>10</sub>-Dbt<sub>11</sub></td><td rowspan="1" colspan="1">Lys-AcDab(&#x003b2;OH)-AcDab(&#x003b2;OH)-Gly-Orn-Pro-His-Lys-Dha</td></tr><tr><td rowspan="1" colspan="1">Triacetylated NOSO-95C (<italic toggle="yes">m/z</italic> 1,391)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;[M&#x02009;+&#x02009;2H]2+</td><td rowspan="1" colspan="1">696</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;y<sub>10</sub></td><td rowspan="1" colspan="1">1,262.7</td><td rowspan="1" colspan="1">129</td><td rowspan="1" colspan="1">Lys<sub>1</sub></td><td rowspan="1" colspan="1">AcDab(&#x003b2;OH)-AcDab(&#x003b2;OH)-Gly-Orn-Pro-His-Lys-Dha-AcLys-Dbt</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1,174.6</td><td rowspan="1" colspan="1">88</td><td rowspan="1" colspan="1">Dbt</td><td rowspan="1" colspan="1">AcDab(&#x003b2;OH)-AcDab(&#x003b2;OH)-Gly-Orn-Pro-His-Lys-Dha-AcLys</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;y<sub>9</sub></td><td rowspan="1" colspan="1">1,104.6</td><td rowspan="1" colspan="1">158</td><td rowspan="1" colspan="1">AcDab(&#x003b2;OH)<sub>2</sub></td><td rowspan="1" colspan="1">AcDab(&#x003b2;OH)-Gly-Orn-Pro-His-Lys-Dha-AcLys-Dbt</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;y<sub>8</sub></td><td rowspan="1" colspan="1">946.6</td><td rowspan="1" colspan="1">158</td><td rowspan="1" colspan="1">AcDab(&#x003b2;OH)<sub>3</sub></td><td rowspan="1" colspan="1">Gly-Orn-Pro-His-Lys-Dha-AcLys-Dbt</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;y<sub>6</sub></td><td rowspan="1" colspan="1">775.5</td><td rowspan="1" colspan="1">171</td><td rowspan="1" colspan="1">Gly<sub>4</sub>-Orn<sub>5</sub></td><td rowspan="1" colspan="1">Pro-His-Lys-Dha-AcLys-Dbt</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">687.4</td><td rowspan="1" colspan="1">88</td><td rowspan="1" colspan="1">Dbt</td><td rowspan="1" colspan="1">Pro-His-Lys-Dha-AcLys</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">517.3</td><td rowspan="1" colspan="1">170</td><td rowspan="1" colspan="1">AcLys<sub>10</sub></td><td rowspan="1" colspan="1">Pro-His-Lys-Dha</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;b<sub>9</sub></td><td rowspan="1" colspan="1">1,132.6</td><td rowspan="1" colspan="1">258 (170&#x02009;+&#x02009;88)</td><td rowspan="1" colspan="1">AcLys<sub>10</sub>-Dbt<sub>11</sub></td><td rowspan="1" colspan="1">Lys-AcDab(&#x003b2;OH)-AcDab(&#x003b2;OH)-Gly-Orn-Pro-His-Lys-Dha</td></tr></tbody></table><graphic xlink:href="mbio.02826-21-t002" position="anchor"/></alternatives><table-wrap-foot><fn fn-type="other" id="ngtab2-1"><label>a</label><p>See also <xref rid="figS5" ref-type="supplementary-material">Fig.&#x000a0;S5</xref>. For bi- and triacetylated NOSO-95C, structures were retroactively assigned. Abbreviation: Ac, acetyl group.</p></fn></table-wrap-foot></table-wrap><supplementary-material position="float" id="figS5" content-type="local-data"><object-id pub-id-type="doi">10.1128/mBio.02826-21.5</object-id><label>FIG&#x000a0;S5</label><p>Fragmentation (MS/MS) spectrum of NOSO-95C (<italic toggle="yes">m/z</italic> 1,265) (A), monoacetylated NOSO-95C (<italic toggle="yes">m/z</italic> 1,307) (B), biacetylated NOSO-95C (<italic toggle="yes">m/z</italic> 1,349) (C), and triacetylated NOSO-95C (<italic toggle="yes">m/z</italic> 1,391) (D). After <italic toggle="yes">in vitro</italic> acetylation, LC-MS/MS was performed as described in Materials and Methods in the main text. Download <inline-supplementary-material id="fS5" xlink:href="mbio.02826-21-sf005.pdf" content-type="local-data">FIG&#x000a0;S5, PDF file, 0.3 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2022 Lanois-Nouri et al.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Lanois-Nouri et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-01-11"/><license license-type="open-access"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="version-of-record">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material><p>The amino group of Dab(&#x003b2;OH)<sub>2</sub> of NOSO-95C was the principal group acetylated by OatA, followed by Dab(&#x003b2;OH)<sub>3</sub> and, to a lesser extent, Lys<sub>10</sub>. Within 15 min, NOSO-95C was totally metabolized by OatA, generating a 100% monoacetylated form modified exclusively at Dab(&#x003b2;OH)<sub>2</sub> (<xref rid="figS4" ref-type="supplementary-material">Fig.&#x000a0;S4A</xref>). Given the complete loss of antibacterial activity in this modified compound, we hypothesized that the amino group of Dab(&#x003b2;OH)<sub>2</sub> was the main target of OatA. We tested this hypothesis by synthesizing NOSO-95179, in which Dab(&#x003b2;OH)<sub>3</sub> was replaced by an Ala residue and Lys<sub>10</sub>-Dbt<sub>11</sub> was removed. This compound had a MIC against <named-content content-type="genus-species">E. coli</named-content> XL1 (P<italic toggle="yes"><sub>lac</sub></italic>-<italic toggle="yes">oatA-Xn</italic>) more than 512 times higher than that of the parental strain XL1 (pUC19), demonstrating that the presence of Dab(&#x003b2;OH)<sub>3</sub> and Lys<sub>10</sub> is not essential for the mechanism of resistance via acetylation. NOSO-95179 was then reacted with purified OatA in the presence of acetyl-CoA. After 24 h of incubation, LC-MS/MS analysis confirmed the presence of the Dab(&#x003b2;OH)<sub>2</sub> monoacetylated form only. After 24 h of incubation with acetyl-CoA and OatA, NOSO-95179 also displayed a loss of antibacterial activity and of protein synthesis inhibition capacity (<xref rid="figS6" ref-type="supplementary-material">Fig.&#x000a0;S6</xref>).</p><supplementary-material position="float" id="figS6" content-type="local-data"><object-id pub-id-type="doi">10.1128/mBio.02826-21.6</object-id><label>FIG&#x000a0;S6</label><p>Characterization of OatA activity against a NOSO-95179 analog. (A) LCMS analysis of NOSO-95179 (<italic toggle="yes">m/z</italic> 1,022) acetylated derivatives after 24 h of reaction with acetyl-CoA and odilorhabdin acetyltransferase A (OatA): the form present was 100% monoacetylated (<italic toggle="yes">m/z</italic> 1,064). (B) MS/MS fragmentation analysis of monoacetylated NOSO-95179 (<italic toggle="yes">m/z</italic> 1,064): acetylation of the amine group on Dab(&#x003b2;OH)<sub>2</sub>. (C) Antibacterial activity assay for NOSO-95179 after 24 h of reaction with acetyl-CoA (1), and OatA (2), or both (3) against <named-content content-type="genus-species">E. coli</named-content> ATCC 2592. (D) Inhibition of synthesis of the GFP reporter protein in the <named-content content-type="genus-species">E. coli</named-content> cell-free transcription-translation system by NOSO-95179 after 24 h of reaction with acetyl-CoA, OatA, or both. Gentamicin (10 &#x003bc;M) was used as a positive control. The data shown are the means of three experiments &#x000b1; SD. Download <inline-supplementary-material id="fS6" xlink:href="mbio.02826-21-sf006.pdf" content-type="local-data">FIG&#x000a0;S6, PDF file, 0.1 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2022 Lanois-Nouri et al.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Lanois-Nouri et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-01-11"/><license license-type="open-access"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="version-of-record">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material></sec><sec id="s2-6"><title>Structural basis for the poor antimicrobial activity of acetylated ODLs.</title><p>The binding sites of AGs and ODLs are adjacent to each other on the bacterial ribosome (<xref rid="B18" ref-type="bibr">18</xref>). It would, therefore, be interesting to compare the resistance strategies developed by bacteria against AGs with those against ODLs involving the expression of GNAT enzymes. AGs are broad-spectrum bactericidal compounds used to treat severe infections. For example, streptomycin, produced by <named-content content-type="genus-species">Streptomyces griseus</named-content>, was the first compound of this class to be identified. AGs contain typically one aminocyclitol ring linked via a glycosidic bond to several amino-modified sugars. AGs bind to helix 44 of the 16S rRNA in the 30S ribosomal subunit, causing translational errors and the inhibition of ribosome translocation. The <italic toggle="yes">N</italic>-acetylation of particular amino groups in AGs prevents the formation of some of the critical H-bonds between the drug and the 16S rRNA, resulting in a loss of antibacterial activity (<xref rid="B36" ref-type="bibr">36</xref>). The genes encoding aminoglycoside-modifying enzymes are generally carried by plasmids and transposons. It has been suggested that these enzymes originate from organisms producing aminoglycosides. In contrast, ODLs interact simultaneously with the 16S rRNA and the anticodon loop of the A-site aminoacyl-tRNA. Indeed, the &#x003b1;-amine of the Lys<sub>1</sub> residue of the antibiotic forms an H-bond with the nonbridging phosphate oxygen of residue C32 in the anticodon loop of the A-site tRNA, whereas other ODL residues form multiple H-bonds with the residues of the 16S rRNA, in helices 31, 32, and 34 (<xref rid="B18" ref-type="bibr">18</xref>). Previous studies have shown that removal of Dab(&#x003b2;OH)<sub>2</sub> or <sc>d</sc>-Orn<sub>5</sub> from the ODL molecule strongly decreases both inhibitory capacity and the antibacterial activity of the altered compound (<xref rid="B37" ref-type="bibr">37</xref>). These data suggest that the amino group of the Dab(&#x003b2;OH)<sub>2</sub> residue is of crucial importance for antibacterial activity. A high-resolution X-ray crystal structure of the bacterial 70S ribosome in complex with an ODL analog revealed that the side chains of Dab(&#x003b2;OH)<sub>2</sub> and <sc>d</sc>-Orn<sub>5</sub> interact directly with the sugar-phosphate backbone of nucleotides C1051 and C1214 of 16S rRNA helix 34, suggesting that they are likely to be important for the inhibition of translation (<xref rid="B18" ref-type="bibr">18</xref>). It is not, therefore, surprising that OatA confers resistance to ODLs predominantly by acetylating the side chain amino group of Dab(&#x003b2;OH)<sub>2</sub>, leading to a rapid loss of the translation-inhibiting and antibacterial properties of the compound. <italic toggle="yes">In silico</italic> modeling of the acetyl group on the side chain amino group of the Dab(&#x003b2;OH)<sub>2</sub> of the ribosome-bound ODL (<xref rid="fig4" ref-type="fig">Fig.&#x000a0;4</xref>) suggested that the likely placement of the oxygen and the methyl of the acetyl group next to the negatively charged phosphates of residues C1051 and C1200, respectively, would result in repulsion and decreased binding of acetylated ODL to the ribosome, providing a possible structural basis for the poor antimicrobial activity of the acetylated compounds.</p><fig position="float" id="fig4"><label>FIG&#x000a0;4</label><caption><p>Structural basis for resistance to ODLs via acetylation by OatA enzyme. (A) Overview of the ODL drug-binding site (yellow) in the <named-content content-type="genus-species">Thermus thermophilus</named-content> 70S ribosome viewed as a cross-cut section through the nascent peptide exit tunnel. The 30S subunit is shown in light yellow, the 50S subunit is in light blue, the mRNA is in magenta, and the A- and P-site tRNAs are colored green and dark blue, respectively. The structure is from PDB entry <ext-link xlink:href="https://doi.org/10.2210/pdb6CAE/pdb" ext-link-type="uri" assigning-authority="pdb">6CAE</ext-link> (<xref rid="B18" ref-type="bibr">18</xref>). (B to D) Close-up views of the <italic toggle="yes">in silico</italic>-modeled acetyl group (red) onto the side chain amino group of the Dab(&#x003b2;OH)<sub>2</sub> of the ribosome-bound ODL (yellow) catalyzed by OatA. <named-content content-type="genus-species">E. coli</named-content> numbering of the 16S rRNA nucleotides is used. Note that the oxygen of the modeled acetyl group is placed next to the two negatively charged nonbridging oxygens of the C1051 phosphate, likely resulting in repulsion between them and decreased binding.</p></caption><graphic xlink:href="mbio.02826-21-f004" position="anchor"/></fig><p>Interestingly, nonproteinogenic amino acids, such as Dab(&#x003b2;OH), have very rarely been described in previous studies (<xref rid="B38" ref-type="bibr">38</xref>), suggesting that OatA is selective. A similar observation was reported for edeines (EDEs), linear antibiotic pentapeptides produced by the soil bacterium <named-content content-type="genus-species">Brevibacillus brevis</named-content>. EDEs contain four nonproteinogenic amino acids. At high concentrations, they block bacterial translation by inhibiting the binding of fMet-tRNA to the P site of the 30S ribosomal subunit. EdeQ, an <italic toggle="yes">N</italic>-acetyltransferase, was shown to confer resistance to EDEs via the acetylation of a primary amino group of the unusual amino acid 2,3-diaminopropionic acid. The resulting <italic toggle="yes">N</italic>-acetylated compounds are unable to inhibit both translation <italic toggle="yes">in vitro</italic> and bacterial growth <italic toggle="yes">in vivo</italic> (<xref rid="B7" ref-type="bibr">7</xref>).</p></sec><sec id="s2-7"><title><italic toggle="yes">oatA</italic> distribution, phylogenetic analysis, and linkage with the <italic toggle="yes">odl</italic> locus in the <italic toggle="yes">Xenorhabdus</italic> and <italic toggle="yes">Photorhabdus</italic> genomes.</title><p>A search of the NCBI database (15 July 2021) identified OatA orthologs (70% amino acid identity to OatA over at least 80% of the total length of the protein) only in phylum <italic toggle="yes">Proteobacteria</italic> and exclusively in a few <italic toggle="yes">Xenorhabdus</italic> and <italic toggle="yes">Photorhabdus</italic> species. Furthermore, no OatA orthologs were found when the MGnify database of the European Bioinformatics Institute (<ext-link xlink:href="https://www.ebi.ac.uk/metagenomics/sequence-search/search/phmmer" ext-link-type="uri">https://www.ebi.ac.uk/metagenomics/sequence-search/search/phmmer</ext-link>), which includes all types of microbiome-derived sequence data, was queried with the OatA<sub>Xn</sub> sequence (15 July 2021).</p><p>For the genus <italic toggle="yes">Photorhabdus</italic>, a molecular phylogenetic analysis (<xref rid="fig5" ref-type="fig">Fig.&#x000a0;5A</xref>) showed OatA to be present on several phylogenetic branches with a common ancestor corresponding to the former subspecies <italic toggle="yes">P. luminescens</italic> (<xref rid="B39" ref-type="bibr">39</xref>). OatA was, indeed, identified in clades P-I to P-III, which have now been raised to species level (<italic toggle="yes">P. bodei</italic>, <italic toggle="yes">P. kayaii</italic>, <italic toggle="yes">P. laumondii</italic>, and <italic toggle="yes">P. luminescens</italic>) (<xref rid="fig5" ref-type="fig">Fig.&#x000a0;5A</xref>) (<xref rid="B40" ref-type="bibr">40</xref>). The BLASTP and phylogenetic data confirm that OatA is absent from other major <italic toggle="yes">Photorhabdus</italic> clades, such as the P-IV clade, containing species with clinical strains (<italic toggle="yes">P. asymbiotica</italic> and <italic toggle="yes">P. australis</italic>) (<xref rid="fig5" ref-type="fig">Fig.&#x000a0;5</xref>). In the genus <italic toggle="yes">Xenorhabdus</italic>, OatA is found in only a few species spread over three clades (clades II, III, and IV) (<xref rid="fig5" ref-type="fig">Fig.&#x000a0;5</xref>).</p><fig position="float" id="fig5"><label>FIG&#x000a0;5</label><caption><p>Distribution of acetyltransferase protein (OatA) orthologs among <italic toggle="yes">Xenorhabdus</italic> and <italic toggle="yes">Photorhabdus</italic> genomes. (A) Phylogenetic reconstruction based on 44 complete genome sequences of <italic toggle="yes">Photorhabdus</italic> and <italic toggle="yes">Xenorhabdus</italic> bacterial strains. Genomic similarity was estimated with Mash software (<xref rid="B50" ref-type="bibr">50</xref>), which calculates the distance between two genomes. This distance is correlated with average nucleotide identity (ANI) such that <italic toggle="yes">D</italic>&#x02009;=&#x02009;1 &#x02212; ANI. A tree was constructed dynamically from all the pairwise distances of the genome set, with the neighbor-joining JavaScript package. The clustering was computed from all-pair distances&#x02009;of &#x02264;0.06 (&#x02248;94% ANI) corresponding to the standard ANI defining a species group. P-I to P-V are phylogenetic clades of <italic toggle="yes">Photorhabdus</italic> species; C-I to C-IV are phylogenetic clades of <italic toggle="yes">Xenorhabdus</italic> species. The names of the strains with <italic toggle="yes">oatA</italic> gene orthologs (see panel B) are shown in a particular color, depending on their species phylogenetic clade. (B) Phylogenetic analysis by the maximum likelihood method for the acetyltransferase protein (Oat). The orthologs of <italic toggle="yes">X. nematophila</italic> F1 OatA protein were identified by BLASTP analysis; only proteins with a sequence identity of &#x02265;70% and minLrap&#x02009;of &#x02265;80% were considered to be orthologs. The OatA sequence of <italic toggle="yes">Halomonas</italic> has been added as an outgroup sequence. The amino acid sequences were aligned by the Muscle algorithm, with the Seaview platform (<xref rid="B51" ref-type="bibr">51</xref>). Evolutionary analyses were inferred by the maximum likelihood method, based on the JTT matrix-based model (<xref rid="B52" ref-type="bibr">52</xref>), and were conducted in MEGA7 (<xref rid="B53" ref-type="bibr">53</xref>). The tree is drawn to scale, with branch lengths measured as the number of substitutions per site; bootstrap values are shown from 100 replicates. The analysis was performed on 35 amino acid sequences. All positions containing gaps and missing data were eliminated. In total, 132 positions were included in the final data set. The names of the strains are shown in a particular color according to the species phylogenetic clade (see panel A).</p></caption><graphic xlink:href="mbio.02826-21-f005" position="anchor"/></fig><p>Given the large size of NRPS genes and their numerous intragenic repeats, reflecting the repetitive cycle of reactions catalyzed by enzymatic modules, we used DNA chips to obtain a complete picture of the occurrence profiles of the <italic toggle="yes">odl</italic>-BGC genes and their linkage to the <italic toggle="yes">oatA</italic> gene in strains from our laboratory collection of <italic toggle="yes">Xenorhabdus</italic> and <italic toggle="yes">Photorhabdus</italic> (57 and 20 strains, respectively) (<xref rid="B41" ref-type="bibr">41</xref>). The Agilent oligonucleotide microarray used in this study carries two or three 60-mer probes per sequence of interest. The 40 sequences of interest were either NRPS-PKS modules or nonmodular genes associated with NRPS-PKS loci identified in the genomic sequences of <italic toggle="yes">X. nematophila</italic> ATCC 19061<sup>T</sup> and <italic toggle="yes">P. laumondii</italic> TT01<sup>T</sup> (<xref rid="figS7" ref-type="supplementary-material">Fig.&#x000a0;S7</xref>). We found that all <italic toggle="yes">X. nematophila</italic> strains, including the first ODL-producing strain ever described, K102, harbored the complete 44.5-kb locus carrying both the <italic toggle="yes">odl</italic>-BGC and the self-resistance gene, <italic toggle="yes">oatA</italic>. Complete <italic toggle="yes">odl</italic> loci, including <italic toggle="yes">oatA</italic> genes, were also present in <italic toggle="yes">P. laumondii</italic> and some <italic toggle="yes">Photorhabdus</italic> species (<italic toggle="yes">P. luminescens</italic>, <italic toggle="yes">P. laumondii</italic>, and <italic toggle="yes">P. kayaii</italic>). The <italic toggle="yes">oatA</italic> orthologs identified in <italic toggle="yes">Photorhabdus</italic> genomes flanked the <italic toggle="yes">odl</italic>-BGC locus (<xref rid="fig6" ref-type="fig">Fig.&#x000a0;6A</xref>). In contrast, within genus <italic toggle="yes">Xenorhabdus</italic>, this genomic organization was conserved only in the species <italic toggle="yes">X. nematophila</italic> (<xref rid="fig6" ref-type="fig">Fig.&#x000a0;6B</xref>). In both cases, the flanking regions of the <italic toggle="yes">odl</italic>-BGC locus have two remarkable features: their high content of enzyme-encoding genes, such as that encoding OatA, and their low GC content (<xref rid="fig6" ref-type="fig">Fig.&#x000a0;6</xref>). These features suggest that the large modular locus involved in ODL synthesis and self-resistance to ODLs was recently constructed by the addition of genomic modules in an as-yet-unidentified ancestor, followed by horizontal transfer to some <italic toggle="yes">Photorhabdus</italic> and <italic toggle="yes">X. nematophila</italic> species. Furthermore, the orphan <italic toggle="yes">oatA</italic> orthologs (i.e., <italic toggle="yes">odl</italic>-BGC independent) present in the genomes of <named-content content-type="genus-species">Xenorhabdus hominickii</named-content> and <italic toggle="yes">Xenorhabdus</italic> species from phylogenetic clade IV are located in radically different genomic environments; for this reason, they are considered to be <italic toggle="yes">oatA</italic>-like genes (<xref rid="fig6" ref-type="fig">Fig.&#x000a0;6B</xref>). Interestingly, the <italic toggle="yes">oatA</italic>-like orthologs of clade IV frequently present features of rearrangements likely to lead to pseudogenization (<xref rid="figS8" ref-type="supplementary-material">Fig.&#x000a0;S8</xref>). These independent shuffling events in <italic toggle="yes">oatA</italic>-like genes strongly suggest the action of purifying selection in <italic toggle="yes">Xenorhabdus</italic>. Finally, a previous exhaustive description of regions of genomic plasticity (RGPs) in the genomes of <italic toggle="yes">X. nematophila</italic> ATCC 19061 and <italic toggle="yes">P. laumondii</italic> TT01 identified the <italic toggle="yes">odl</italic>-BGC locus as a mobile genetic element (MGE) (<xref rid="B42" ref-type="bibr">42</xref>). As described previously (<xref rid="B42" ref-type="bibr">42</xref>), such MGEs are composed of different genomic subregions, in this case the ODL synthesis and the ODL self-resistance subregions.</p><fig position="float" id="fig6"><label>FIG&#x000a0;6</label><caption><p>Genomic environment of the <italic toggle="yes">oatA</italic> gene in the <italic toggle="yes">Photorhabdus</italic> (A) and <italic toggle="yes">Xenorhabdus</italic> (B) genomes. Blue box, <italic toggle="yes">odl</italic>-BGC region; pink boxes, genomic regions framing the <italic toggle="yes">odl</italic>-BGC region encoding several enzymes, including OatA (the asterisk shows a highly shuffled subregion with a variable gene content according to the strain); gray boxes, core genome (different motifs indicate different regions of core genomes). GC content ({G or C}/{A, T, G, or C}) was calculated for a sliding window with a length of 25 nucleotides and plotted with SnapGene software (from Insightful Science). (A) Strains from clade P-I containing the <italic toggle="yes">oatA</italic> ortholog include <italic toggle="yes">P. luminescens</italic> subsp. <italic toggle="yes">luminescens</italic> DSM 3368, <italic toggle="yes">P. luminescens</italic> HIM3, <italic toggle="yes">P. namnanoensis</italic> PB45.5, and <italic toggle="yes">Photorhabdus</italic> sp. H1. Strains from the clade P-I which totally lack the <italic toggle="yes">oatA</italic> ortholog include <italic toggle="yes">P. aegyptiae</italic> BA1, <italic toggle="yes">Photorhabdus</italic> sp. LN2, NBAII HiPL 101, and NBAII Hb 105. Strains from clade P-II include <italic toggle="yes">P. bodei</italic> CN4 and LJ24-63, <italic toggle="yes">P. kayaii</italic> M-HU2, C-HU2, and HUG-39, <italic toggle="yes">P. kleinii</italic> S9-53 and S10-54, and <italic toggle="yes">Photorhabdus</italic> sp. CRCIAP01. Strains from clade P-III include <italic toggle="yes">P. laumondii</italic> TT01, HP88, and IL9. Strains from clade P-IV include <italic toggle="yes">P. asymbiotica</italic> ATCC 43949; <italic toggle="yes">P. australis</italic> subsp. <italic toggle="yes">australis</italic> DSM 17609, <italic toggle="yes">P. cinnerea</italic> DSM 19724, and <italic toggle="yes">P. heterorhabditis</italic> VMG. Strains from clade P-V include <italic toggle="yes">P. temperata</italic> J3, Meg1, and M1021, <italic toggle="yes">P. thracensis</italic> DSM 15199, <italic toggle="yes">P. khani</italic> NC19, and <italic toggle="yes">P. tasmaniensis</italic> DSM 22387. (B) <italic toggle="yes">X. nematophila</italic> strains include F1, ATCC 19061, K102 (CNCMI-4530), Anatoliense, Websteri, and C2-3. <italic toggle="yes">X. hominickii</italic> strains include ANU1 and DSM 17903. Strains from clade C-IV include <italic toggle="yes">Xenorhabdus</italic> sp. KK7.4 and KJ12.1, <italic toggle="yes">X. innexi</italic> HGB1681 and DSM 16336, <italic toggle="yes">X. stockiae</italic> DSM 17904, and <italic toggle="yes">X. cabanillassii</italic> 17905 and JM26. The <italic toggle="yes">oatA</italic> ortholog is totally absent from the strains of <italic toggle="yes">Xenorhabdus</italic> phylogenetic clades C-I and C-III, illustrated here by the strains <italic toggle="yes">X. bovienii</italic> CS03, <italic toggle="yes">X. doucetiae</italic> FRM16, and <italic toggle="yes">X. poinarii</italic> G6.</p></caption><graphic xlink:href="mbio.02826-21-f006" position="anchor"/></fig><supplementary-material position="float" id="figS7" content-type="local-data"><object-id pub-id-type="doi">10.1128/mBio.02826-21.7</object-id><label>FIG&#x000a0;S7</label><p>Oligonucleotide probe selection and odilorhabdin microarray synthesis. Two or three 60-mer oligonucleotide probes were designed by Imaxio (Biop&#x000f4;le Clermont-Limagne, Saint-Beauzire, France) for each NRPS-PKS genomic module or nonmodule gene of the <italic toggle="yes">odl</italic>-BGC from <italic toggle="yes">X. nematophila</italic> ATCC 19061 and <italic toggle="yes">P. laumondii</italic> TT01. The oligonucleotide probes have a mean <italic toggle="yes">T<sub>m</sub></italic> of 80.37&#x000b0;C (&#x000b1;2.25&#x000b0;C), a mean GC of 43.33%, and no significant match elsewhere on the two bacterial genomes (less than 80% similarity over 30 nucleotides) to prevent cross-hybridization. Microarrays (8x15K) were synthesized with Agilent ink-jet technology (Agilent Technologies, Inc., Santa Clara, CA). Genomic DNA extraction, microarray hybridization, and microarray image analysis were done. We obtained bacterial genomic DNA for 77 strains from the DGIMI laboratory collection according to the method of Brenner et al. (2). For each genomic DNA, 0.5 &#x003bc;g of material was hydrolyzed with AluI and RsaI, denatured for 5 min at 95&#x000b0;C, and Cy3-labeled with a genomic DNA enzymatic labeling kit (Agilent Technologies) according to the manufacturer&#x02019;s recommendations. Labeled targets were purified with Amicon 30-kDa columns (Millipore) and displayed a specific activity of 23 to 45 pmol of Cy3/&#x003bc;g. The Cy3-labeled genomic DNA was hybridized with the 60-mer oligonucleotide microarray at 65&#x000b0;C for 24 h. The arrays were scanned with Agilent Scanner (laser constant intensity) with the following settings: Dynamic AutoFocus, PMT Cy3 100%, 20 bit-data format, pixel resolution 5 &#x003bc;m. Microarray image files were extracted after intra-array normalization with Feature Extraction 10.7.3 software (Agilent Technologies). The mean background signal was calculated with the negative controls and subtracted from the mean signal for each spot. ODL biosynthesis gene distribution and profile clustering were done. After normalization and background correction, a sequence was considered present in the target genome if the hybridization signal intensity exceeded 1,000 for at least one of the probes. The hybridization profiles of each strain were transformed into binary numerical values (0, gene absent; 1, gene present). The dendrogram was generated by a hierarchical analysis of the distribution patterns (presence/absence) of the ODL-targeted probes according to the unweighted pair group method arithmetic mean (UPGMA) distance method and the Gower similarity coefficient (3), with Bionumerics software version 4.5 (Applied-Maths, Sint-Martens-Latem, Belgium). The taxonomic identities of the 77 strains used for hybridization experiment are shown on the right side of the dendrogram. The names of the NRPS-PKS genomic modules or nonmodule genes of the <italic toggle="yes">odl</italic>-BGC are shown at the top of the dendrogram. Download <inline-supplementary-material id="fS7" xlink:href="mbio.02826-21-sf007.pdf" content-type="local-data">FIG&#x000a0;S7, PDF file, 0.4 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2022 Lanois-Nouri et al.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Lanois-Nouri et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-01-11"/><license license-type="open-access"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="version-of-record">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material><supplementary-material position="float" id="figS8" content-type="local-data"><object-id pub-id-type="doi">10.1128/mBio.02826-21.8</object-id><label>FIG&#x000a0;S8</label><p>Pseudogenization of the <italic toggle="yes">oatA</italic>-like gene in the genomes of the strains from <italic toggle="yes">Xenorhabdus</italic> clade C-IV. Download <inline-supplementary-material id="fS8" xlink:href="mbio.02826-21-sf008.pdf" content-type="local-data">FIG&#x000a0;S8, PDF file, 0.1 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2022 Lanois-Nouri et al.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Lanois-Nouri et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-01-11"/><license license-type="open-access"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="version-of-record">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material></sec><sec id="s2-8"><title>Intrinsic odilorhabdin resistance and OatA-dependent self-resistance in EPN-symbiotic bacteria.</title><p>We first investigated the functionality of <italic toggle="yes">oatA</italic>-like and <italic toggle="yes">oatA</italic> from <italic toggle="yes">Xenorhabdus</italic> and <italic toggle="yes">Photorhabdus</italic> by cloning and expressing these <italic toggle="yes">oatA</italic> genes in <named-content content-type="genus-species">E. coli</named-content>, as described above. As all <italic toggle="yes">X. nematophila</italic> OatA proteins have the same sequence, only the gene from the F1 strain was cloned. <xref rid="tab3" ref-type="table">Table&#x000a0;3</xref> clearly shows that the cloning and expression of the <italic toggle="yes">oatA</italic> genes from <italic toggle="yes">Photorhabdus</italic> and <italic toggle="yes">X. nematophila</italic> rendered <named-content content-type="genus-species">E. coli</named-content> resistant to NOSO-95C, with a MIC of at least 512&#x02009;&#x003bc;g/mL. However, no significant resistance to NOSO-95C (<xref rid="tab3" ref-type="table">Table&#x000a0;3</xref>) was observed after the cloning of <italic toggle="yes">Xenorhabdus</italic> orphan <italic toggle="yes">oatA</italic>-like genes displaying full sequence identity to <italic toggle="yes">oatA-Xn</italic> or truncated sequences (<xref rid="figS8" ref-type="supplementary-material">Fig.&#x000a0;S8</xref>).</p><table-wrap position="float" id="tab3"><label>TABLE&#x000a0;3</label><caption><p>MICs of NOSO-95C against <named-content content-type="genus-species">E. coli</named-content> recombinant strains expressing <italic toggle="yes">oatA</italic> or <italic toggle="yes">oatA</italic>-like genes and <italic toggle="yes">X. nematophila</italic> wild-type or mutant strains<xref rid="ngtab3-1" ref-type="table-fn"><sup><italic toggle="yes">a</italic></sup></xref></p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1">Type of strain</th><th rowspan="1" colspan="1">MIC (&#x003bc;g/mL) of NOSO-95C</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><named-content content-type="genus-species">E. coli</named-content> expressing <italic toggle="yes">oatA</italic> from <italic toggle="yes">Photorhabdus</italic></td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;XL1(P<italic toggle="yes"><sub>lac</sub></italic>-<italic toggle="yes">oatA-Pla-</italic>HP88)</td><td rowspan="1" colspan="1">512</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;XL1(P<italic toggle="yes"><sub>lac</sub></italic>-<italic toggle="yes">oatA-Pla-</italic>TT01)</td><td rowspan="1" colspan="1">512</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;XL1(P<italic toggle="yes"><sub>lac</sub></italic>-<italic toggle="yes">oatA-Pk</italic>)</td><td rowspan="1" colspan="1">512</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;XL1(P<italic toggle="yes"><sub>lac</sub></italic>-<italic toggle="yes">oatA-Plu</italic>)</td><td rowspan="1" colspan="1">1,024</td></tr><tr><td rowspan="1" colspan="1"><named-content content-type="genus-species">E. coli</named-content> expressing <italic toggle="yes">oatA-like</italic> from <italic toggle="yes">Xenorhabdus</italic></td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;XL1(P<italic toggle="yes"><sub>lac</sub></italic>-<italic toggle="yes">oatA-like-Xc-</italic>JM26)</td><td rowspan="1" colspan="1">8</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;XL1(P<italic toggle="yes"><sub>lac</sub></italic>-<italic toggle="yes">oatA-like-Xc-</italic>DSM 17905)</td><td rowspan="1" colspan="1">8</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;XL1(P<italic toggle="yes"><sub>lac</sub></italic>-<italic toggle="yes">oatA-like-Xh</italic>)</td><td rowspan="1" colspan="1">32</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;XL1(P<italic toggle="yes"><sub>lac</sub></italic>-<italic toggle="yes">oatA-like-Xi</italic>)</td><td rowspan="1" colspan="1">4</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;XL1(P<italic toggle="yes"><sub>lac</sub></italic>-<italic toggle="yes">oatA-like-Xs</italic>)</td><td rowspan="1" colspan="1">8</td></tr><tr><td rowspan="1" colspan="1">Controls</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;XL1 (pUC19)</td><td rowspan="1" colspan="1">8</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;XL1(P<italic toggle="yes"><sub>lac</sub></italic>-<italic toggle="yes">oatA-Xn</italic>)</td><td rowspan="1" colspan="1">1,024</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">X. nematophila</italic> strain F1</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Wild type</td><td rowspan="1" colspan="1">&#x0003e;2,048</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Mutant strain (&#x00394;<italic toggle="yes">ngrA</italic>)</td><td rowspan="1" colspan="1">&#x0003e;2,048</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Double mutant strain (&#x00394;<italic toggle="yes">ngrA</italic> &#x00394;<italic toggle="yes">oatA</italic>)</td><td rowspan="1" colspan="1">256</td></tr></tbody></table><graphic xlink:href="mbio.02826-21-t003" position="anchor"/></alternatives><table-wrap-foot><fn fn-type="other" id="ngtab3-1"><label>a</label><p><italic toggle="yes">Pla</italic>, <italic toggle="yes">P. laumondii</italic>; <italic toggle="yes">Pk</italic>, <italic toggle="yes">P. kayaii</italic> KR04; <italic toggle="yes">Plu</italic>, <italic toggle="yes">P. luminescens</italic> Hb; <italic toggle="yes">Xc</italic>, <italic toggle="yes">X. cabanillasii</italic>; <italic toggle="yes">Xh</italic>, <italic toggle="yes">X. hominickii</italic> DSM 17903; <italic toggle="yes">Xi</italic>, <italic toggle="yes">X. innexi</italic> UY61; <italic toggle="yes">Xs</italic>, <italic toggle="yes">X. stockiae</italic> DSM 17904.</p></fn></table-wrap-foot></table-wrap><p>We needed an <italic toggle="yes">oatA</italic> mutant for assessment of the relative contribution of OatA to overall ODL resistance. We constructed this mutant in an <italic toggle="yes">ngrA</italic>-deficient strain of <italic toggle="yes">X. nematophila</italic>, to prevent the suicide of the producing strain. A comparison of the MICs of NOSO-95C against <italic toggle="yes">X. nematophila</italic> (<italic toggle="yes">ngrA</italic> mutant) and its derivative <italic toggle="yes">oatA</italic> strain revealed a decrease in resistance by a factor of more than 8. However, a high MIC (256&#x02009;&#x003bc;g/mL) was still observed for the <italic toggle="yes">oatA</italic> mutant (<xref rid="tab3" ref-type="table">Table&#x000a0;3</xref>), suggesting the existence of another intrinsic resistance mechanism in <italic toggle="yes">X. nematophila</italic>. We therefore evaluated ODL resistance in a large collection of EPN-symbiotic bacteria. The ODL resistance profiles of <italic toggle="yes">Photorhabdus</italic> strains were simple. Basically, only strains from clades I to III (<xref rid="tab4" ref-type="table">Table&#x000a0;4</xref>) with both the <italic toggle="yes">odl</italic>-BGC locus and an <italic toggle="yes">oatA</italic> self-resistance gene were resistant to ODLs, with an MIC of&#x02009;&#x0003e;512&#x02009;&#x003bc;g/mL. For <italic toggle="yes">X. nematophila</italic>, the first ODL-producing strain identified, <italic toggle="yes">X. nematophila</italic> K102 (<xref rid="B18" ref-type="bibr">18</xref>), and the other <italic toggle="yes">X. nematophila</italic> strains displayed high-level resistance to NOSO-95C (<xref rid="tab4" ref-type="table">Table&#x000a0;4</xref>). This resistance was associated with the presence of <italic toggle="yes">oatA</italic> in the genome (<xref rid="figS7" ref-type="supplementary-material">Fig.&#x000a0;S7</xref>), confirming that <italic toggle="yes">X. nematophila</italic> has developed a mechanism of self-resistance to ODLs. However, other <italic toggle="yes">Xenorhabdus</italic> species displayed various degrees of susceptibility to the natural compound. For the most susceptible strains (<xref rid="tab4" ref-type="table">Table&#x000a0;4</xref>), MICs ranged from 8 to 128&#x02009;&#x003bc;g/mL. In contrast, the strains of several other species were highly resistant despite the absence of an <italic toggle="yes">oatA</italic> gene (e.g., <italic toggle="yes">X. koppenhoeferi</italic> DSM 18168) (<xref rid="figS7" ref-type="supplementary-material">Fig.&#x000a0;S7</xref>) or the presence of a nonfunctional <italic toggle="yes">oatA</italic>-like resistance gene (like <italic toggle="yes">X. innexi</italic> DSM 16336) (<xref rid="figS8" ref-type="supplementary-material">Fig.&#x000a0;S8</xref>). As-yet-unexplained OatA-independent resistance phenomena also occur in <named-content content-type="genus-species">M. morganii</named-content> (<xref rid="tab1" ref-type="table">Table&#x000a0;1</xref>). Our findings also indicate that there is no correlation between intrinsic resistance to ODLs and taxonomic clade in <italic toggle="yes">Xenorhabdus</italic> (<xref rid="tab4" ref-type="table">Table&#x000a0;4</xref>).</p><table-wrap position="float" id="tab4"><label>TABLE&#x000a0;4</label><caption><p>MICs of NOSO-95C against <italic toggle="yes">Xenorhabdus</italic> and <italic toggle="yes">Photorhabdus</italic> strains</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1">Strain</th><th rowspan="1" colspan="1">Clade</th><th rowspan="1" colspan="1">MIC (&#x003bc;g/mL) of NOSO-95C</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><italic toggle="yes">Xenorhabdus</italic> species</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">Xenorhabdus bovienii</named-content> DSM 4766</td><td rowspan="1" colspan="1"><italic toggle="yes">Xenorhabdus</italic> clade (C-III)</td><td rowspan="1" colspan="1">16</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">Xenorhabdus cabanillasii</named-content> DSM 17905</td><td rowspan="1" colspan="1"><italic toggle="yes">Xenorhabdus</italic> clade (C-IV)</td><td rowspan="1" colspan="1">1,024</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">Xenorhabdus doucetiae</named-content> FRM16</td><td rowspan="1" colspan="1"><italic toggle="yes">Xenorhabdus</italic> clade (C-I)</td><td rowspan="1" colspan="1">1,024</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">Xenorhabdus griffiniae</named-content> DSM 17911</td><td rowspan="1" colspan="1"><italic toggle="yes">Xenorhabdus</italic> clade (C-I)</td><td rowspan="1" colspan="1">32</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">Xenorhabdus hominickii</named-content> DSM 17903</td><td rowspan="1" colspan="1"><italic toggle="yes">Xenorhabdus</italic> clade (C-II)</td><td rowspan="1" colspan="1">32</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">Xenorhabdus indica</named-content> DSM 17382</td><td rowspan="1" colspan="1"><italic toggle="yes">Xenorhabdus</italic> clade (C-IV)</td><td rowspan="1" colspan="1">128</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">Xenorhabdus innexi</named-content> UY61<xref rid="ngtab4-1" ref-type="table-fn"><sup><italic toggle="yes">a</italic></sup></xref></td><td rowspan="1" colspan="1"><italic toggle="yes">Xenorhabdus</italic> clade (C-IV)</td><td rowspan="1" colspan="1">1,024</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">Xenorhabdus ishibashii</named-content> DSM 22670</td><td rowspan="1" colspan="1"><italic toggle="yes">Xenorhabdus</italic> clade (C-I)</td><td rowspan="1" colspan="1">8</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">Xenorhabdus koppenhoeferi</named-content> DSM 18168</td><td rowspan="1" colspan="1"><italic toggle="yes">Xenorhabdus</italic> clade (C-II)</td><td rowspan="1" colspan="1">&#x0003e;512</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">Xenorhabdus mauleonii</named-content> DSM 17908</td><td rowspan="1" colspan="1"><italic toggle="yes">Xenorhabdus</italic> clade (C-II)</td><td rowspan="1" colspan="1">256</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">Xenorhabdus nematophila</named-content> DSM 3370<sup>T</sup></td><td rowspan="1" colspan="1"><italic toggle="yes">Xenorhabdus</italic> clade (C-II)</td><td rowspan="1" colspan="1">&#x0003e;512</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">Xenorhabdus nematophila</named-content> F1<xref rid="ngtab4-1" ref-type="table-fn"><sup><italic toggle="yes">a</italic></sup></xref></td><td rowspan="1" colspan="1"><italic toggle="yes">Xenorhabdus</italic> clade (C-II)</td><td rowspan="1" colspan="1">&#x0003e;2,048</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">Xenorhabdus nematophila</named-content> CNCM I-4530 (K102)<xref rid="ngtab4-1" ref-type="table-fn"><sup><italic toggle="yes">a</italic></sup></xref></td><td rowspan="1" colspan="1"><italic toggle="yes">Xenorhabdus</italic> clade (C-II)</td><td rowspan="1" colspan="1">&#x0003e;2,048</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">Xenorhabdus poinarii</named-content> DSM 4768</td><td rowspan="1" colspan="1"><italic toggle="yes">Xenorhabdus</italic> clade (C-I)</td><td rowspan="1" colspan="1">16</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">Xenorhabdus romanii</named-content> DSM 17910</td><td rowspan="1" colspan="1"><italic toggle="yes">Xenorhabdus</italic> clade (C-I)</td><td rowspan="1" colspan="1">32</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">Xenorhabdus szentirmaii</named-content> DSM 16338</td><td rowspan="1" colspan="1"><italic toggle="yes">Xenorhabdus</italic> clade (C-II)</td><td rowspan="1" colspan="1">32</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">Photorhabdus</italic> species</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<italic toggle="yes">Photorhabdus laumondii</italic> TT01<xref rid="ngtab4-1" ref-type="table-fn"><sup><italic toggle="yes">a</italic></sup></xref></td><td rowspan="1" colspan="1"><italic toggle="yes">Photorhabdus</italic> clade (P-III)</td><td rowspan="1" colspan="1">512</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">Photorhabdus luminescens</named-content> Hb<xref rid="ngtab4-1" ref-type="table-fn"><sup><italic toggle="yes">a</italic></sup></xref></td><td rowspan="1" colspan="1"><italic toggle="yes">Photorhabdus</italic> clade (P-I)</td><td rowspan="1" colspan="1">2,048</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<italic toggle="yes">Photorhabdus kayaii</italic> KR04<xref rid="ngtab4-1" ref-type="table-fn"><sup><italic toggle="yes">a</italic></sup></xref></td><td rowspan="1" colspan="1"><italic toggle="yes">Photorhabdus</italic> clade (P-II)</td><td rowspan="1" colspan="1">512</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">Photorhabdus asymbiotica</named-content> ATCC 43949</td><td rowspan="1" colspan="1"><italic toggle="yes">Photorhabdus</italic> clade (P-V)</td><td rowspan="1" colspan="1">64</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">Photorhabdus tasmaniensis</named-content> NZ48<xref rid="ngtab4-1" ref-type="table-fn"><sup><italic toggle="yes">a</italic></sup></xref></td><td rowspan="1" colspan="1"><italic toggle="yes">Photorhabdus</italic> clade (P-IV)</td><td rowspan="1" colspan="1">64</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;<named-content content-type="genus-species">Photorhabdus temperata</named-content> XlNach<xref rid="ngtab4-1" ref-type="table-fn"><sup><italic toggle="yes">a</italic></sup></xref></td><td rowspan="1" colspan="1"><italic toggle="yes">Photorhabdus</italic> clade (P-IV)</td><td rowspan="1" colspan="1">16</td></tr></tbody></table><graphic xlink:href="mbio.02826-21-t004" position="anchor"/></alternatives><table-wrap-foot><fn fn-type="other" id="ngtab4-1"><label>a</label><p>From DGIMI laboratory collection.</p></fn></table-wrap-foot></table-wrap><p>Our study clearly reveals that the resistance gene, <italic toggle="yes">oatA</italic>, is found exclusively in EPN-symbiotic bacteria. It is therefore confined to EPN-infected insects and IJs harboring specific bacterial symbiont species. However, bacterial symbionts can persist for several weeks in the cadaver of the insect before reassociating with new generations of IJs, and it has been suggested that they need to produce broad-spectrum antimicrobial compounds to protect the insect cadaver from competing soil microorganisms (<xref rid="B43" ref-type="bibr">43</xref>). This raises the question of whether the ODLs exert selection pressure in EPN-infested cadavers, favoring the HGT of the <italic toggle="yes">oatA</italic> self-resistance gene to bacteria with no intrinsic ODL production capacity. It has been shown in bacterial competition experiments that <named-content content-type="genus-species">Staphylococcus saprophyticus</named-content> is eliminated following its introduction into growing cultures <italic toggle="yes">in vitro</italic> (mimicking the hemolymph) of either the xenocoumacin mutant strain or the ODL mutant strain but that this bacterium is able to grow in the presence of the <italic toggle="yes">ngrA</italic> strain, indicating that the main water-soluble antimicrobial agent, xenocoumacin, and ODLs were not required to eliminate the competitor. In addition, natural infection experiments with insect larvae have shown that NgrA-independent antibiotics are involved in <italic toggle="yes">S. saprophyticus</italic> control. Finally, it has been shown that NgrA-derived compounds from <italic toggle="yes">X. nematophila</italic> serve as signals for nematode reproduction <italic toggle="yes">in vivo</italic> (<xref rid="B30" ref-type="bibr">30</xref>).</p><p>In response to the urgent need to address the lack of effective treatments for the increasing number of human infections caused by Gram-negative multidrug-resistant bacteria, ODLs, a promising new family of antibiotics produced by <italic toggle="yes">X. nematophila</italic>, are currently in preclinical development. EPN-symbiotic bacteria have developed a successful strategy to avoid being killed by their own antibiotic products. OatA, a GNAT encoded by the <italic toggle="yes">odl</italic>-BGC, confers selective resistance to ODLs by predominantly acetylating the side chain amino group of one of its rare amino acids, leading to a rapid loss of the ability to inhibit translation and the antibacterial properties of these compounds. A link has been established between antibiotic production by bacteria residing in environments not significantly affected by human antibiotic use and antimicrobial resistance and was first reported by Benveniste and Davies in 1973 (<xref rid="B44" ref-type="bibr">44</xref>). We show here that ODL resistance genes are present only in bacterial species belonging to the same phylogenetic cluster as the producing strain, which is specific to a particular niche, soil-dwelling EPNs. In addition, no trace of <italic toggle="yes">oatA</italic> HGT was detected, excluding the presence of this gene in the principal bacteria pathogenic to humans. This is an important point in the development of a new antibiotic. This work thus provides a perfect example of the coevolution of antibiotic production and self-resistance mechanisms in Gram-negative bacteria.</p></sec></sec><sec sec-type="materials|methods" id="s3"><title>MATERIALS AND METHODS</title><sec id="s3-1"><title>Bacterial strains, plasmids, and growth conditions.</title><p>The strains and plasmids used in this study are listed in <xref rid="tabS1" ref-type="supplementary-material">Table&#x000a0;S1</xref>. Bacteria were routinely grown in Luria-Bertani (LB) medium at 28&#x000b0;C (<italic toggle="yes">X. nematophila</italic>) or 37&#x000b0;C (<named-content content-type="genus-species">E. coli</named-content>). When required, antibiotics were used at the following final concentrations: kanamycin, 20 &#x003bc;g/mL (or 10 &#x003bc;g/mL for chromosome selection); gentamicin, 15 &#x003bc;g/mL; chloramphenicol, 20 &#x003bc;g/mL for <named-content content-type="genus-species">E. coli</named-content> strains and 15 &#x003bc;g/mL for <italic toggle="yes">X. nematophila</italic> (or 8 &#x003bc;g/mL for chromosome selection); and ampicillin, 100 &#x003bc;g/mL. P<italic toggle="yes"><sub>tet</sub></italic> constructs were induced by adding anhydrotetracycline (aTc) at a final concentration of 0.2 &#x003bc;g/mL. The P<italic toggle="yes"><sub>ara</sub></italic> ET&#x003b3;A (full-length <italic toggle="yes">recE</italic>, <italic toggle="yes">recT</italic>, <italic toggle="yes">red&#x003b3;</italic>, and <italic toggle="yes">recA</italic>) and P<italic toggle="yes"><sub>ara</sub></italic> &#x003b3;&#x003b2;&#x003b1;A (<italic toggle="yes">red&#x003b3;</italic>, <italic toggle="yes">red&#x003b2;</italic>, <italic toggle="yes">red&#x003b1;</italic>, and <italic toggle="yes">recA</italic>) operons were induced by adding 10% <sc>l</sc>-arabinose. P<italic toggle="yes"><sub>lac</sub></italic> constructs were induced by adding IPTG at a final concentration of 0.2&#x02009;mM. We added 100&#x02009;&#x003bc;g/mL of diaminopimelic acid (DAP) to cultures of the <named-content content-type="genus-species">E. coli</named-content> WM3064 strain, which is auxotrophic for this amino acid.</p><supplementary-material position="float" id="tabS1" content-type="local-data"><object-id pub-id-type="doi">10.1128/mBio.02826-21.9</object-id><label>TABLE&#x000a0;S1</label><p>Strains and plasmids used in this study. Download <inline-supplementary-material id="tS1" xlink:href="mbio.02826-21-st001.pdf" content-type="local-data">Table&#x000a0;S1, PDF file, 0.1 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2022 Lanois-Nouri et al.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Lanois-Nouri et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-01-11"/><license license-type="open-access"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="version-of-record">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material></sec><sec id="s3-2"><title>Molecular genetic techniques.</title><p>DNA manipulations were performed as previously described (<xref rid="B45" ref-type="bibr">45</xref>). Plasmids were introduced into <named-content content-type="genus-species">E. coli</named-content> by transformation and transferred to <italic toggle="yes">X. nematophila</italic> by conjugative mating with WM3064 as the donor strain (<xref rid="B46" ref-type="bibr">46</xref>). All constructs were sequenced by Eurofins Genomics Germany GmbH. The primers used in this study (IDT) are described in <xref rid="tabS2" ref-type="supplementary-material">Table&#x000a0;S2</xref>.</p><supplementary-material position="float" id="tabS2" content-type="local-data"><object-id pub-id-type="doi">10.1128/mBio.02826-21.10</object-id><label>TABLE&#x000a0;S2</label><p>Primers used in this study. Download <inline-supplementary-material id="tS2" xlink:href="mbio.02826-21-st002.pdf" content-type="local-data">Table&#x000a0;S2, PDF file, 0.1 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2022 Lanois-Nouri et al.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Lanois-Nouri et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-01-11"/><license license-type="open-access"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="version-of-record">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material></sec><sec id="s3-3"><title>Recombineering construction of p15A-P<italic toggle="yes"><sub>tet</sub>-odl</italic>-BGC-mob.</title><p>As previously described by Fu et al. (<xref rid="B29" ref-type="bibr">29</xref>), genomic DNA from <italic toggle="yes">X. nematophila</italic> was first digested with NcoI and SphI to generate a 45.2-kb fragment containing the <italic toggle="yes">odl</italic>-BGC locus and surrounding genes. Homology arms were ordered as oligonucleotides and attached by p15A-cm PCR with pACYC184 as a template. One homology arm started at the start codon of the first gene cloned (<italic toggle="yes">ectB</italic> gene) and extended 80&#x02009;bp downstream. The other homology arm started at the SphI site and extended 80&#x02009;bp upstream. After linear-plus-linear homologous recombination by RecET in GB05-dir activated with arabinose (0.3%), the <italic toggle="yes">odl</italic> locus was inserted directly into the p15A vector to create the p15A-<italic toggle="yes">odl</italic>-BGC containing a 44.5-kb <italic toggle="yes">odl</italic>-BGC fragment (four <italic toggle="yes">odl</italic> genes plus the surrounding genes). For expression of the <italic toggle="yes">odl</italic>-BGC locus, homology arms were ordered as oligonucleotides and attached to the Km<sup>r</sup>-Tet<sup>r</sup>-P<sub>LtetO1</sub> fragment of pSC101. One homology arm started at the start codon of the <italic toggle="yes">ectB</italic> gene and extended 57&#x02009;bp downstream. The other homology arm started 216 bases from the p15A origin and extended 52&#x02009;bp upstream. After linear-plus-circular homologous recombination by Red&#x003b1;&#x003b2; in GB08-red activated with arabinose (0.3%), the Km<sup>r</sup>-Tet<sup>r</sup>-P<sub>LtetO1</sub> fragment was inserted into the p15A-<italic toggle="yes">odl</italic>-BGC plasmid between the p15A origin and the start codon of the <italic toggle="yes">ectB</italic> gene, to create p15A- P<italic toggle="yes"><sub>tet</sub>-odl</italic>-BGC containing the 44.5-kb <italic toggle="yes">odl</italic>-BGC fragment under the control of the P<sub>LtetO1</sub> promoter. For complementation of the <italic toggle="yes">odl</italic> mutant with p15A-P<italic toggle="yes"><sub>tet</sub>-odl</italic>-BGC, homology arms were ordered as oligonucleotides and attached to the Gm<sup>r</sup>-<italic toggle="yes">mob</italic> fragment of pBBR1-MCS5. One homology arm started at the end of the kanamycin resistance gene sequence and extended 57&#x02009;bp downstream. The other homology arm started at the end of Tet<sup>r</sup> and extended 54&#x02009;bp upstream. After linear-plus-circular homologous recombination by Red&#x003b1;&#x003b2; in GB08-red activated with arabinose (0.3%), the Gm<sup>r</sup>-<italic toggle="yes">mob</italic> fragment was inserted directly into the p15A-P<italic toggle="yes"><sub>tet</sub>-odl</italic>-BGC plasmid, between Km<sup>r</sup> and Tet<sup>r</sup>, to create the mobilizable plasmid p15A-P<italic toggle="yes"><sub>tet</sub></italic>-<italic toggle="yes">odl</italic>-BGC-mob.</p></sec><sec id="s3-4"><title>Insertion of diverse genes into <named-content content-type="genus-species">E. coli</named-content> XL1 Blue MRF&#x02032;.</title><p>For identification of the odilorhabdin self-resistance gene, the regions upstream and downstream from the <italic toggle="yes">odl</italic> locus of <italic toggle="yes">X. nematophila</italic> F1 were amplified by PCR with the L-<italic toggle="yes">ectB</italic>-KpnI and R-c-SacI primers (for <italic toggle="yes">abc</italic> genes) or the L-d-KpnI and R-j-SacI primers (for <italic toggle="yes">defghij</italic> genes), respectively, and inserted into pUC19 digested with KpnI and SacI. Genes <italic toggle="yes">a</italic>, <italic toggle="yes">b</italic>, and <italic toggle="yes">c</italic> were amplified separately, by PCR, with L-<italic toggle="yes">ectB</italic>-KpnI and R-<italic toggle="yes">ectB</italic>-SacI, L-b-KpnI and R-b-SacI, and L-c-KpnI and R-c-SacI, respectively, and inserted into pUC19 digested with KpnI and SacI. All these constructs were used to transform <named-content content-type="genus-species">E. coli</named-content> XL1-Blue MRF&#x02032; and were assessed separately in odilorhabdin MIC assays after the addition of IPTG. We assessed the functionality of diverse OatA proteins from <italic toggle="yes">Photorhabdus</italic> strains or OatA-like proteins from <italic toggle="yes">Xenorhabdus</italic> strains, by amplifying the corresponding genes by PCR with appropriate primers (<xref rid="tabS2" ref-type="supplementary-material">Table&#x000a0;S2</xref>) and inserting the amplicon between the KpnI and SacI sites of pUC19. The resulting constructs were then used to transform the <named-content content-type="genus-species">E. coli</named-content> XL1 Blue MRF&#x02032; strain, and odilorhabdin MIC assays were performed after adding IPTG. The <italic toggle="yes">ngrA</italic> PCR fragment was inserted into the pBBR1-MCS2 broad-host-range vector with the L-ngrA-EcoRI and R-ngrA-BamHI primers digested with EcoRI and BamHI, and the resulting construct was used to transform <named-content content-type="genus-species">E. coli</named-content> XL1 Blue MRF&#x02032; before the addition of p15A-P<italic toggle="yes"><sub>tet</sub></italic>-<italic toggle="yes">odl</italic>-BGC.</p></sec><sec id="s3-5"><title>Cloning, overexpression, and purification of OatA.</title><p>For purification of the <italic toggle="yes">N</italic>-acetyltransferase, the <italic toggle="yes">oatA</italic> gene was first amplified from <italic toggle="yes">X. nematophila</italic> genomic DNA with the F-Nterm-oatA-NdeI and R-Stop-oatA-SalI primers (<xref rid="tabS2" ref-type="supplementary-material">Table&#x000a0;S2</xref>), digested with NdeI and SalI, and inserted into pET-28a previously digested with the same enzymes, at a position downstream from the T7 promoter and in fusion with the His tag, yielding pET-<italic toggle="yes">oatA</italic>. Fresh precultures of the overexpressing strain BL21(DE3) harboring the pET-<italic toggle="yes">oatA</italic> plasmid were grown overnight in 20&#x02009;mL of LB broth supplemented with 20&#x02009;&#x003bc;g/mL of kanamycin at 35&#x000b0;C. We inoculated 200&#x02009;mL of LB broth supplemented with 20&#x02009;&#x003bc;g/mL of kanamycin in a 1-L Erlenmeyer flask with fresh overnight preculture (2% [vol/vol]) and incubated it at 35&#x000b0;C with shaking until the culture reached an optical density at 600 nm (OD<sub>600</sub>) of 0.4. The cells were induced by incubation with 0.2&#x02009;mM IPTG for 3 h at 35&#x000b0;C. Cell pellets from two flasks were recovered by centrifugation at 6,000&#x02009;&#x000d7;&#x02009;<italic toggle="yes">g</italic> for 10&#x02009;min, pooled, and washed once with saline. The resulting cell pellet was resuspended in 4&#x02009;mL of 50&#x02009;mM HEPES buffer (pH 7.5), 100&#x02009;mM NaCl, and 2% glycerol (ACT buffer). Cells were lysed by processing the cell suspension in a Fast-Prep-24 instrument (MP Biomedicals) for 20&#x02009;s at a speed of 4 m/s with 100-&#x003bc;m glass beads/cell at a suspension ratio of 1/3. The samples were then centrifuged (13,000&#x02009;&#x000d7;&#x02009;<italic toggle="yes">g</italic> for 5&#x02009;min) and the supernatants were recovered. Cell pellets were washed once with ACT buffer and the supernatants were pooled. Imidazole was added to a concentration of 10&#x02009;mM before enzyme purification by the HisPur nickel-nitrilotriacetic acid (Ni-NTA) Superflow agarose batch method (Thermo Fisher Scientific). Briefly, 1&#x02009;mL of equilibrated Ni-NTA resin was added to 3&#x02009;mL of sample. The mixture was incubated for 1 h with gentle shaking and was then washed four times with 25&#x02009;mM imidazole in ACT wash buffer. Three elutions were performed, with 150, 250, and 500&#x02009;mM imidazole. The eluates obtained with 250 and 500&#x02009;mM imidazole were pooled and subjected to dialysis overnight against 75&#x02009;mM HEPES at 4&#x000b0;C with a PurA-Lyzer cutoff at 3.5&#x02009;kDa. Glycerol was added to the purified His-tagged OatA enzyme at a final concentration of 10% before storage at &#x02212;20&#x000b0;C.</p></sec><sec id="s3-6"><title>Production and LC-MS analysis of secondary metabolites.</title><p>For the detection of secondary metabolites in the culture supernatants, bacteria were collected from 96-h cultures by centrifugation at 7,000&#x02009;&#x000d7;&#x02009;<italic toggle="yes">g</italic> for 10&#x02009;min and the supernatants after filtration on 0.2-&#x003bc;m filters were analyzed by LC-MS on an Agilent 1260 Infinity system coupled to an Agilent 6120 quadrupole mass spectrometer. The conditions for high-performance liquid chromatography (HPLC) separation were as follows: a Symmetry C<sub>18</sub> analytical column (5&#x02009;&#x003bc;m, 4.6&#x02009;mm&#x02009;by&#x02009;150&#x02009;mm; Waters Corporation) was used in positive mode, the injection volume was 100&#x02009;&#x003bc;L, mobile phase A was 0.1% trifluoroacetic acid in water, mobile phase B was acetonitrile, and the linear gradient was 0% mobile phase B&#x02013;100% mobile phase A at 0 min to 80% mobile phase B&#x02013;20% mobile phase A at 40 min. UV detection was performed at 210&#x02009;nm. During separation, the flow rate was 0.7&#x02009;mL/min, and the column temperature was 37&#x000b0;C.</p></sec><sec id="s3-7"><title><italic toggle="yes">In vitro</italic> acetylation of NOSO-95C.</title><p><italic toggle="yes">N</italic>-Acetylation of NOSO-95C or NOSO-95179 was performed in a polystyrene microtube with purified His-tagged OatA diluted to 300&#x02009;&#x003bc;g/mL in 75&#x02009;mM HEPES (pH 7.5) supplemented with glycerol (5.7% [vol/vol]), 250&#x02009;&#x003bc;M NOSO-95C or NOSO-95179, and 750&#x02009;&#x003bc;M acetyl-CoA in 75&#x02009;mM HEPES (pH 7.5) for 24 h at 28&#x000b0;C. Aliquots were sampled at 15 min, 4 h, and 24 h.</p></sec><sec id="s3-8"><title>LC-MS/MS analysis.</title><p>The acetylated NOSO-95C compounds were analyzed by LC-MS/MS. Data were obtained in the positive mode on a Waters Alliance LC-MS/MS system (Waters Synapt G2-S mass spectrometer, Waters UPLC Acquity H-class). The HPLC column used was a Phenomenex EVO C18 T HPLC column (100&#x02009;by&#x02009;2.1&#x02009;mm, 1.7&#x02009;&#x003bc;m) maintained at 25&#x000b0;C. Solvent A was H<sub>2</sub>O&#x02009;plus&#x02009;0.1% (vol/vol) formic acid, solvent B was acetonitrile&#x02009;plus&#x02009;0.1% (vol/vol) formic acid, and the flow rate was 0.5&#x02009;mL/min. The mobile phase composition was 100% solvent A from 0&#x02009;min to 5&#x02009;min, ramped to 30% solvent B at 10&#x02009;min. Sample injection volume was 0.1&#x02009;&#x003bc;L. UV-visible detection was by absorbance at 200 to 500&#x02009;nm. An ion spray (IS) voltage of 3,000&#x02009;V, a source temperature of 140&#x000b0;C, a desolvation temperature of 450&#x000b0;C, a declustering potential (DP) of 30 V, and a collision energy (CE) in the range of 20 to 60&#x02009;V were applied.</p></sec><sec id="s3-9"><title>Antibiotic activity.</title><p>Total antimicrobial activity was assessed with <named-content content-type="genus-species">Klebsiella pneumoniae</named-content> ATCC 43816 as a target of strains harboring <italic toggle="yes">odl</italic>-BGC loci. We placed 15&#x02009;&#x003bc;L of an overnight bacterial culture on a plate containing Mueller-Hinton broth (MHB; Bio-Rad) supplemented with 1.4% agarose (Sigma), and aTc (200&#x02009;ng/mL) was added when required. After incubation for 72 h at 28&#x000b0;C, the bacteria were exposed to chloroform fumes for 30 min and allowed to dry in air for 30 min. The <named-content content-type="genus-species">Klebsiella pneumoniae</named-content> ATCC 43816 (200&#x02009;&#x003bc;L of an overnight culture) target strain was then added to 8&#x02009;mL of MHB supplemented with 0.7% agarose, which was poured over the bacterial colony. After incubation for 24 h at 37&#x000b0;C, zones of growth inhibition were observed. The antibiotic activity of the samples acetylated <italic toggle="yes">in vitro</italic> was also assessed, as follows. We spotted 10 &#x003bc;L of sample onto Mueller-Hinton II (Becton, Dickinson) medium supplemented with 1.4% agarose. We poured an overnight culture of <named-content content-type="genus-species">E. coli</named-content> ATCC 25922 in LB broth (2% [vol/vol]) over the plate. The plate was allowed to dry and was then incubated at 35&#x000b0;C for 20 h. We then observed the plates to check for zones of growth inhibition.</p></sec><sec id="s3-10"><title>IVTT assay.</title><p>The effect of <italic toggle="yes">in vitro</italic> acetylation on bacterial protein synthesis was investigated in the Expressway cell-free <named-content content-type="genus-species">E. coli</named-content> expression system (Invitrogen). The green fluorescent protein (GFP) gene was amplified from the pCmGFP plasmid (<xref rid="B47" ref-type="bibr">47</xref>) and inserted into pEXP5-CT TOPO (Thermo Fisher Scientific), and the resulting plasmid was used as a template for <italic toggle="yes">in vitro</italic> transcription and translation (IVTT). Reactions were performed according to the manufacturer&#x02019;s protocol, in 50 &#x003bc;L of reaction mixture, in the wells of a black polystyrene 96-half-well microplate (Greiner). Feed buffer was added after 30 min of incubation, to ensure optimal protein synthesis. Reactions were initiated by adding 1&#x02009;&#x003bc;g of plasmid DNA. The plate was incubated at 30&#x000b0;C and fluorescence was measured every 20 min (&#x003bb;<sub>ex</sub>&#x02009;=&#x02009;475&#x02009;nm; &#x003bb;<sub>em</sub>&#x02009;=&#x02009;520&#x02009;nm) with a Spark M10 microplate reader (Tecan). Fluorescence from GFP synthesis was recorded at 20&#x02009;min after addition of feed buffer using GraphPad Prism 6 software. Gentamicin was used as positive control at 10&#x02009;&#x003bc;M.</p></sec><sec id="s3-11"><title>Gene expression and identification of the compounds produced in complemented strains.</title><p>We investigated the production of secondary metabolites in complemented strains, by incubating 100-mL broth cultures of &#x00394;<italic toggle="yes">xcnKL</italic>::<italic toggle="yes">odl1</italic> (MCS5) and &#x00394;<italic toggle="yes">xcnKL</italic>::<italic toggle="yes">odl1</italic> (p15A-P<italic toggle="yes"><sub>tet</sub></italic>-<italic toggle="yes">odl</italic>-BGC-mob) strains with gentamicin and aTc at 28&#x000b0;C for 78&#x02009;h, centrifuging the cultures, and passing the supernatants through 0.2-&#x003bc;m filters and concentrating them 10-fold for LC-MS analysis. Natural odilorhabdins (NOSO-95A, -B, and -C) and xenocoumacin 1 (Xcn 1) were identified in culture supernatants by LC-MS on an Agilent 1260 Infinity system coupled to an Agilent 6120 quadrupole mass spectrometer. The conditions for HPLC separation were as follows: a Symmetry C<sub>18</sub> analytical column (5&#x02009;&#x003bc;m, 4.6&#x02009;mm&#x02009;by&#x02009;150&#x02009;mm; Waters Corporation) was used in positive mode, the injection volume was 100&#x02009;&#x003bc;L, mobile phase A was 0.1% trifluoroacetic acid in water, mobile phase B was acetonitrile, and the linear gradient was 0% mobile phase B&#x02013;100% mobile phase A at 0 min to 80% mobile phase B&#x02013;20% mobile phase A at 40 min. UV detection was performed at 210&#x02009;nm. During separation, the flow rate was 0.7&#x02009;mL/min, and the column temperature was 37&#x000b0;C.</p></sec><sec id="s3-12"><title>Construction of <italic toggle="yes">X. nematophila</italic> mutants.</title><p>For the construction of a &#x00394;<italic toggle="yes">oatA</italic> mutant, we first constructed an <italic toggle="yes">ngrA</italic>-deficient strain, to prevent the suicide of the <italic toggle="yes">X. nematophila</italic> producer strain. The upstream and downstream regions of the <italic toggle="yes">ngrA</italic> gene were amplified by PCR with the L-PCR1-ngrA-XbaI and R-PCR1-ngrA-BamHI primers for the upstream region (579&#x02009;bp) and the L-ngrA2bis-BamHI and R-ngrA2bis-ApaI primers for the downstream region (522&#x02009;bp). The two fragments obtained were inserted, together with the 3.8-kb BamHI fragment omega interposon cassette from pHP45-&#x003a9;Cm conferring resistance to chloramphenicol, into pJQ200SK digested with XbaI and ApaI for insertion of the &#x003a9;Cam cassette between the two PCR fragments. The resulting plasmid, pJQ-<italic toggle="yes">ngrA</italic>::&#x003a9;Cm, was used to transform <named-content content-type="genus-species">E. coli</named-content> strain WM3064 and was introduced into <italic toggle="yes">X. nematophila</italic> F1 by mating. Allelic exchange was performed as previously described (<xref rid="B48" ref-type="bibr">48</xref>). Omega insertion was confirmed by PCR analysis, and the loss of NRP products was checked by antibiosis tests. The clone obtained was called the &#x00394;<italic toggle="yes">ngrA</italic> clone. For construction of the &#x00394;<italic toggle="yes">ngrA</italic> &#x00394;<italic toggle="yes">oatA</italic> double mutant, the upstream and downstream regions of the <italic toggle="yes">oatA</italic> gene were amplified by PCR with the appropriate primer pairs, L-SacI-b/R-SpeI-oatA (upstream) and L-SalI-oatA/R-ApaI-odl1 (downstream), generating a 595-bp PCR1 fragment and a 611-bp PCR2 fragment, respectively (<xref rid="tabS2" ref-type="supplementary-material">Table&#x000a0;S2</xref>). The pJQ-KmT1 plasmid was then digested with SpeI and SalI and the 2-kb KmT1 fragment containing the Km<sup>r</sup> cassette and T1 terminators was purified with the Zymo gel purification kit (Ozyme). These three fragments were inserted into pJQ200SK digested with SacI and ApaI to introduce the Km-T1 cassette between the two PCR fragments. The pJQ-<italic toggle="yes">oatA</italic>::KmT1 plasmid was then introduced, by mating, into the <italic toggle="yes">X. nematophila ngrA</italic> mutant, and allelic exchange was performed. Km<sup>r</sup> and Sac<sup>r</sup> exconjugants were selected on LB agar supplemented with 4% sucrose and kanamycin. The KmT1 insertion was checked by PCR analysis with the two primers L-b-KpnI/R-Km-PvuI amplifying a 1,791-bp fragment (<xref rid="tabS2" ref-type="supplementary-material">Table&#x000a0;S2</xref>), with confirmation by DNA sequencing (Eurofins Genomics). The resulting recombinant clone was named the &#x00394;<italic toggle="yes">ngrA</italic> &#x00394;<italic toggle="yes">oatA</italic> clone.</p></sec><sec id="s3-13"><title>MIC determination.</title><p>MICs were determined in triplicate, in accordance with CLSI guidelines but with modifications for <italic toggle="yes">Xenorhabdus</italic> and <italic toggle="yes">Photorhabdus</italic> strains and for <named-content content-type="genus-species">E. coli</named-content> constructs (<xref rid="B49" ref-type="bibr">49</xref>). For <italic toggle="yes">Xenorhabdus</italic> and <italic toggle="yes">Photorhabdus</italic> strains, inoculum preparation was modified as follows: 3&#x02009;mL of MHB II (Becton, Dickinson, Thermo Fisher Scientific) was inoculated with bacteria grown overnight in LB broth and cultured to an OD<sub>600</sub> of 0.11 to 0.15. The inoculum was prepared as described in the CLSI guide, with a 1:20 dilution in saline. Multiplates were incubated for 24 h at 28&#x000b0;C or for longer if the results were unclear. For <named-content content-type="genus-species">E. coli</named-content> constructs, a modified method of inoculum preparation was used in which about 10 colonies were picked from MH agar supplemented with 100&#x02009;&#x003bc;g/mL of ampicillin and used to inoculate 10&#x02009;mL of MHB II supplemented with 100&#x02009;&#x003bc;g/mL of ampicillin. The inoculum was incubated for 1.5 to 2 h at 35&#x000b0;C, with shaking at 150&#x02009;rpm, until the OD<sub>600</sub> reached 0.15 to 0.25. IPTG was added at a concentration of 0.2&#x02009;mM for induction, and the culture was incubated for 30&#x02009;min at 35&#x000b0;C, with shaking at 150&#x02009;rpm. The inoculum was then diluted 1:20 in saline to obtain the final inoculum. The reaction medium consisted of MHB II supplemented with 0.2&#x02009;mM IPTG. For other <named-content content-type="genus-species">E. coli</named-content> constructs requiring aTc induction, aTc was added to the isolate used for streaking and the reaction medium at a concentration of 200&#x02009;ng/mL. In all other respects, the procedure corresponded to the CLSI method.</p></sec></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>We thank Nad&#x000e8;ge Ginibre and Alban Maurin (CDD AI-INRA) for assistance with the cloning experiments and recombineering, respectively. We also thank the Laboratoire de Mesures Physiques&#x02019; analytical facilities of Montpellier University for LC-MS/MS analyses. The English text was edited by Alex Edelman &#x00026; Associates.</p></ack><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Newman</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Cragg</surname>
<given-names>GM</given-names></string-name></person-group>. <year>2016</year>. <article-title>Natural products as sources of new drugs from 1981 to 2014</article-title>. <source>J Nat Prod</source>
<volume>79</volume>:<fpage>629</fpage>&#x02013;<lpage>661</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acs.jnatprod.5b01055</pub-id>.<pub-id pub-id-type="pmid">26852623</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Davies</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Davies</surname>
<given-names>D</given-names></string-name></person-group>. <year>2010</year>. <article-title>Origins and evolution of antibiotic resistance</article-title>. <source>Microbiol Mol Biol Rev</source>
<volume>74</volume>:<fpage>417</fpage>&#x02013;<lpage>433</lpage>. doi:<pub-id pub-id-type="doi">10.1128/MMBR.00016-10</pub-id>.<pub-id pub-id-type="pmid">20805405</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hopwood</surname>
<given-names>DA</given-names></string-name></person-group>. <year>2007</year>. <article-title>How do antibiotic-producing bacteria ensure their self-resistance before antibiotic biosynthesis incapacitates them?</article-title>
<source>Mol Microbiol</source>
<volume>63</volume>:<fpage>937</fpage>&#x02013;<lpage>940</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05584.x</pub-id>.<pub-id pub-id-type="pmid">17238916</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Waglechner</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Wright</surname>
<given-names>GD</given-names></string-name></person-group>. <year>2017</year>. <article-title>Antibiotic resistance: it&#x02019;s bad, but why isn&#x02019;t it worse?</article-title>
<source>BMC Biol</source>
<volume>15</volume>:<fpage>84</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12915-017-0423-1</pub-id>.<pub-id pub-id-type="pmid">28915805</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Arthur</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Brisson-No&#x000eb;l</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Courvalin</surname>
<given-names>P</given-names></string-name></person-group>. <year>1987</year>. <article-title>Origin and evolution of genes specifying resistance to macrolide, lincosamide and streptogramin antibiotics: data and hypotheses</article-title>. <source>J Antimicrob Chemother</source>
<volume>20</volume>:<fpage>783</fpage>&#x02013;<lpage>802</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jac/20.6.783</pub-id>.<pub-id pub-id-type="pmid">3326871</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ogawara</surname>
<given-names>H</given-names></string-name></person-group>. <year>2019</year>. <article-title>Comparison of antibiotic resistance mechanisms in antibiotic-producing and pathogenic bacteria</article-title>. <source>Molecules</source>
<volume>24</volume>:<fpage>3430</fpage>. doi:<pub-id pub-id-type="doi">10.3390/molecules24193430</pub-id>.</mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Westman</surname>
<given-names>EL</given-names></string-name>, <string-name><surname>Yan</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Waglechner</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Koteva</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Wright</surname>
<given-names>GD</given-names></string-name></person-group>. <year>2013</year>. <article-title>Self-resistance to the atypical cationic antimicrobial peptide edeine of <italic toggle="yes">Brevibacillus brevis</italic> Vm4 by the N-acetyltransferase EdeQ</article-title>. <source>Chem Biol</source>
<volume>20</volume>:<fpage>983</fpage>&#x02013;<lpage>990</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chembiol.2013.06.010</pub-id>.<pub-id pub-id-type="pmid">23891151</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Adeolu</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Alnajar</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Naushad</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Gupta</surname>
<given-names>RS</given-names></string-name></person-group>. <year>2016</year>. <article-title>Genome-based phylogeny and taxonomy of the &#x02018;Enterobacteriales&#x02019;: proposal for Enterobacterales ord. nov. divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morganellaceae fam. nov., and Budviciaceae fam. nov</article-title>. <source>Int J Syst Evol Microbiol</source>
<volume>66</volume>:<fpage>5575</fpage>&#x02013;<lpage>5599</lpage>. doi:<pub-id pub-id-type="doi">10.1099/ijsem.0.001485</pub-id>.<pub-id pub-id-type="pmid">27620848</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dillman</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Chaston</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Adams</surname>
<given-names>BJ</given-names></string-name>, <string-name><surname>Ciche</surname>
<given-names>TA</given-names></string-name>, <string-name><surname>Goodrich-Blair</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Stock</surname>
<given-names>SP</given-names></string-name>, <string-name><surname>Sternberg</surname>
<given-names>PW</given-names></string-name></person-group>. <year>2012</year>. <article-title>An entomopathogenic nematode by any other name</article-title>. <source>PLoS Pathog</source>
<volume>8</volume>:<elocation-id>e1002527</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1002527</pub-id>.<pub-id pub-id-type="pmid">22396642</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Poinar</surname>
<given-names>GO</given-names></string-name>, <string-name><surname>Waggoner</surname>
<given-names>BM</given-names></string-name>, <string-name><surname>Bauer</surname>
<given-names>U-C</given-names></string-name></person-group>. <year>1993</year>. <article-title>Terrestrial soft-bodied protists and other microorganisms in Triassic amber</article-title>. <source>Science</source>
<volume>259</volume>:<fpage>222</fpage>&#x02013;<lpage>224</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.259.5092.222</pub-id>.<pub-id pub-id-type="pmid">17790989</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Osimani</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Milanovi&#x00107;</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Cardinali</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Garofalo</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Clementi</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Ruschioni</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Riolo</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Isidoro</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Loreto</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Galarini</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Moretti</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Petruzzelli</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Micci</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Tonucci</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Aquilanti</surname>
<given-names>L</given-names></string-name></person-group>. <year>2018</year>. <article-title>Distribution of transferable antibiotic resistance genes in laboratory-reared edible mealworms (<italic toggle="yes">Tenebrio molitor</italic> L.)</article-title>. <source>Front Microbiol</source>
<volume>9</volume>:<fpage>2702</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2018.02702</pub-id>.<pub-id pub-id-type="pmid">30510544</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gerrard</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Waterfield</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Vohra</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Ffrench-Constant</surname>
<given-names>R</given-names></string-name></person-group>. <year>2004</year>. <article-title>Human infection with <italic toggle="yes">Photorhabdus asymbiotica</italic>: an emerging bacterial pathogen</article-title>. <source>Microbes Infect</source>
<volume>6</volume>:<fpage>229</fpage>&#x02013;<lpage>237</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.micinf.2003.10.018</pub-id>.<pub-id pub-id-type="pmid">15049334</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Farmer</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Jorgensen</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Grimont</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Akhurst</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Poinar</surname>
<given-names>GO</given-names></string-name>, <string-name><surname>Ageron</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Pierce</surname>
<given-names>GV</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Carter</surname>
<given-names>GP</given-names></string-name>, <string-name><surname>Wilson</surname>
<given-names>KL</given-names></string-name></person-group>. <year>1989</year>. <article-title><italic toggle="yes">Xenorhabdus luminescens</italic> (DNA hybridization group 5) from human clinical specimens</article-title>. <source>J Clin Microbiol</source>
<volume>27</volume>:<fpage>1594</fpage>&#x02013;<lpage>1600</lpage>. doi:<pub-id pub-id-type="doi">10.1128/jcm.27.7.1594-1600.1989</pub-id>.<pub-id pub-id-type="pmid">2768446</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dreyer</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Malan</surname>
<given-names>AP</given-names></string-name>, <string-name><surname>Dicks</surname>
<given-names>LMT</given-names></string-name></person-group>. <year>2018</year>. <article-title>Bacteria of the genus <italic toggle="yes">Xenorhabdus</italic>, a novel source of bioactive compounds</article-title>. <source>Front Microbiol</source>
<volume>9</volume>:<fpage>3177</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2018.03177</pub-id>.<pub-id pub-id-type="pmid">30619229</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tobias</surname>
<given-names>NJ</given-names></string-name>, <string-name><surname>Wolff</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Djahanschiri</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Grundmann</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Kronenwerth</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Shi</surname>
<given-names>Y-M</given-names></string-name>, <string-name><surname>Simonyi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Gr&#x000fc;n</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Shapiro-Ilan</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Pidot</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>Stinear</surname>
<given-names>TP</given-names></string-name>, <string-name><surname>Ebersberger</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Bode</surname>
<given-names>HB</given-names></string-name></person-group>. <year>2017</year>. <article-title>Natural product diversity associated with the nematode symbionts <italic toggle="yes">Photorhabdus</italic> and <italic toggle="yes">Xenorhabdus</italic></article-title>. <source>Nat Microbiol</source>
<volume>2</volume>:<fpage>1676</fpage>&#x02013;<lpage>1685</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41564-017-0039-9</pub-id>.<pub-id pub-id-type="pmid">28993611</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stock</surname>
<given-names>SP</given-names></string-name>, <string-name><surname>Kusakabe</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Orozco</surname>
<given-names>RA</given-names></string-name></person-group>. <year>2018</year>. <article-title>Secondary metabolites produced by <italic toggle="yes">Heterorhabditis</italic> symbionts and their application in agriculture: what we know and what to do next</article-title>. <source>J Nematol</source>
<volume>49</volume>:<fpage>373</fpage>&#x02013;<lpage>383</lpage>. doi:<pub-id pub-id-type="doi">10.21307/jofnem-2017-084</pub-id>.</mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lewis</surname>
<given-names>K</given-names></string-name></person-group>. <year>2020</year>. <article-title>The science of antibiotic discovery</article-title>. <source>Cell</source>
<volume>181</volume>:<fpage>29</fpage>&#x02013;<lpage>45</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2020.02.056</pub-id>.<pub-id pub-id-type="pmid">32197064</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pantel</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Florin</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Dobosz-Bartoszek</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Racine</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Sarciaux</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Serri</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Houard</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Campagne</surname>
<given-names>J-M</given-names></string-name>, <string-name><surname>de Figueiredo</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>Midrier</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Gaudriault</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Givaudan</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lanois</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Forst</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Aumelas</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Cotteaux-Lautard</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Bolla</surname>
<given-names>J-M</given-names></string-name>, <string-name><surname>Vingsbo Lundberg</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Huseby</surname>
<given-names>DL</given-names></string-name>, <string-name><surname>Hughes</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Villain-Guillot</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Mankin</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Polikanov</surname>
<given-names>YS</given-names></string-name>, <string-name><surname>Gualtieri</surname>
<given-names>M</given-names></string-name></person-group>. <year>2018</year>. <article-title>Odilorhabdins, antibacterial agents that cause miscoding by binding at a new ribosomal site</article-title>. <source>Mol Cell</source>
<volume>70</volume>:<fpage>83</fpage>&#x02013;<lpage>94.e7</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molcel.2018.03.001</pub-id>.<pub-id pub-id-type="pmid">29625040</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Imai</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Meyer</surname>
<given-names>KJ</given-names></string-name>, <string-name><surname>Iinishi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Favre-Godal</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Green</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Manuse</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Caboni</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Mori</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Niles</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ghiglieri</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Honrao</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Ma</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Guo</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Makriyannis</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Linares-Otoya</surname>
<given-names>L</given-names></string-name>, <string-name><surname>B&#x000f6;hringer</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Wuisan</surname>
<given-names>ZG</given-names></string-name>, <string-name><surname>Kaur</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Mateus</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Typas</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Savitski</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Espinoza</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>O&#x02019;Rourke</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Nelson</surname>
<given-names>KE</given-names></string-name>, <string-name><surname>Hiller</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Noinaj</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Sch&#x000e4;berle</surname>
<given-names>TF</given-names></string-name>, <string-name><surname>D&#x02019;Onofrio</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lewis</surname>
<given-names>K</given-names></string-name></person-group>. <year>2020</year>. <article-title>Author Correction: a new antibiotic selectively kills Gram-negative pathogens</article-title>. <source>Nature</source>
<volume>580</volume>:<elocation-id>E3</elocation-id>. doi:<pub-id pub-id-type="doi">10.1038/s41586-020-2063-9</pub-id>.<pub-id pub-id-type="pmid">32269338</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Racine</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Gualtieri</surname>
<given-names>M</given-names></string-name></person-group>. <year>2019</year>. <article-title>From worms to drug candidate: the story of odilorhabdins, a new class of antimicrobial agents</article-title>. <source>Front Microbiol</source>
<volume>10</volume>:<fpage>2893</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2019.02893</pub-id>.<pub-id pub-id-type="pmid">31921069</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Gualtieri</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Villain-Guillot</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Givaudan</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Pages</surname>
<given-names>S</given-names></string-name></person-group>. <year>2012</year>. <article-title>Novel peptide derivatives as antibiotics. PCT Int. Appl. WO2013045600A1</article-title>.</mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Racine</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Nordmann</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Pantel</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Sarciaux</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Serri</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Houard</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Villain-Guillot</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Demords</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Vingsbo Lundberg</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Gualtieri</surname>
<given-names>M</given-names></string-name></person-group>. <year>2018</year>. <article-title><italic toggle="yes">In vitro</italic> and <italic toggle="yes">in vivo</italic> characterization of NOSO-502, a novel inhibitor of bacterial translation</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>62</volume>:<elocation-id>e01016-18</elocation-id>. doi:<pub-id pub-id-type="doi">10.1128/AAC.01016-18</pub-id>.<pub-id pub-id-type="pmid">29987155</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhao</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lepak</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Marchillo</surname>
<given-names>K</given-names></string-name>, <string-name><surname>VanHecker</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Andes</surname>
<given-names>DR</given-names></string-name></person-group>. <year>2018</year>. <article-title><italic toggle="yes">In vivo</italic> pharmacodynamic characterization of a novel odilorhabdin antibiotic, NOSO-502, against <italic toggle="yes">Escherichia coli</italic> and <italic toggle="yes">Klebsiella pneumoniae</italic> in a murine thigh infection model</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>62</volume>:<elocation-id>e01067-18</elocation-id>. doi:<pub-id pub-id-type="doi">10.1128/AAC.01067-18</pub-id>.<pub-id pub-id-type="pmid">29987156</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Blanchard</surname>
<given-names>SC</given-names></string-name></person-group>. <year>2018</year>. <article-title>A much-needed boost for the dwindling antibiotic pipeline</article-title>. <source>Mol Cell</source>
<volume>70</volume>:<fpage>3</fpage>&#x02013;<lpage>5</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molcel.2018.03.023</pub-id>.<pub-id pub-id-type="pmid">29625037</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pantel</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Juarez</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Serri</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Boucinha</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Lessoud</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Lanois</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Givaudan</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Racine</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Gualtieri</surname>
<given-names>M</given-names></string-name></person-group>. <year>2021</year>. <article-title>Missense mutations in the CrrB protein mediate odilorhabdin derivative resistance in <italic toggle="yes">Klebsiella pneumoniae</italic></article-title>. <source>Antimicrob Agents Chemother</source>
<volume>65</volume>:<elocation-id>e00139-21</elocation-id>. doi:<pub-id pub-id-type="doi">10.1128/AAC.00139-21</pub-id>.</mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vizcaino</surname>
<given-names>MI</given-names></string-name>, <string-name><surname>Guo</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Crawford</surname>
<given-names>JM</given-names></string-name></person-group>. <year>2014</year>. <article-title>Merging chemical ecology with bacterial genome mining for secondary metabolite discovery</article-title>. <source>J Ind Microbiol Biotechnol</source>
<volume>41</volume>:<fpage>285</fpage>&#x02013;<lpage>299</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10295-013-1356-5</pub-id>.<pub-id pub-id-type="pmid">24127069</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tobias</surname>
<given-names>NJ</given-names></string-name>, <string-name><surname>Mishra</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Gupta</surname>
<given-names>DK</given-names></string-name>, <string-name><surname>Sharma</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Thines</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Stinear</surname>
<given-names>TP</given-names></string-name>, <string-name><surname>Bode</surname>
<given-names>HB</given-names></string-name></person-group>. <year>2016</year>. <article-title>Genome comparisons provide insights into the role of secondary metabolites in the pathogenic phase of the <italic toggle="yes">Photorhabdus</italic> life cycle</article-title>. <source>BMC Genomics</source>
<volume>17</volume>:<fpage>537</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12864-016-2862-4</pub-id>.<pub-id pub-id-type="pmid">27488257</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Ke</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Engel</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Shi</surname>
<given-names>Y-M</given-names></string-name>, <string-name><surname>Robinson</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Bingol</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Bowen</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Louie</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Evans</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Miyamoto</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Cheng</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Kosina</surname>
<given-names>S</given-names></string-name>, <string-name><surname>De Raad</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Silva</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Luhrs</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lubbe</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Hoyt</surname>
<given-names>DW</given-names></string-name>, <string-name><surname>Francavilla</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Otani</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Deutsch</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Washton</surname>
<given-names>NM</given-names></string-name>, <string-name><surname>Rubin</surname>
<given-names>EM</given-names></string-name>, <string-name><surname>Mouncey</surname>
<given-names>NJ</given-names></string-name>, <string-name><surname>Visel</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Northen</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Cheng</surname>
<given-names>J-F</given-names></string-name>, <string-name><surname>Bode</surname>
<given-names>HB</given-names></string-name>, <string-name><surname>Yoshikuni</surname>
<given-names>Y</given-names></string-name></person-group>. <year>2019</year>. <article-title>CRAGE enables rapid activation of biosynthetic gene clusters in undomesticated bacteria</article-title>. <source>Nat Microbiol</source>
<volume>4</volume>:<fpage>2498</fpage>&#x02013;<lpage>2510</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41564-019-0573-8</pub-id>.<pub-id pub-id-type="pmid">31611640</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fu</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Bian</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Hu</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Seibert</surname>
<given-names>PM</given-names></string-name>, <string-name><surname>Plaza</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Xia</surname>
<given-names>L</given-names></string-name>, <string-name><surname>M&#x000fc;ller</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Stewart</surname>
<given-names>AF</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name></person-group>. <year>2012</year>. <article-title>Full-length RecE enhances linear-linear homologous recombination and facilitates direct cloning for bioprospecting</article-title>. <source>Nat Biotechnol</source>
<volume>30</volume>:<fpage>440</fpage>&#x02013;<lpage>446</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nbt.2183</pub-id>.<pub-id pub-id-type="pmid">22544021</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Singh</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Orr</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Divinagracia</surname>
<given-names>E</given-names></string-name>, <string-name><surname>McGraw</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Dorff</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Forst</surname>
<given-names>S</given-names></string-name></person-group>. <year>2015</year>. <article-title>role of secondary metabolites in establishment of the mutualistic partnership between <italic toggle="yes">Xenorhabdus nematophila</italic> and the entomopathogenic nematode <italic toggle="yes">Steinernema carpocapsae</italic></article-title>. <source>Appl Environ Microbiol</source>
<volume>81</volume>:<fpage>754</fpage>&#x02013;<lpage>764</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AEM.02650-14</pub-id>.<pub-id pub-id-type="pmid">25398871</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Beld</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Sonnenschein</surname>
<given-names>EC</given-names></string-name>, <string-name><surname>Vickery</surname>
<given-names>CR</given-names></string-name>, <string-name><surname>Noel</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Burkart</surname>
<given-names>MD</given-names></string-name></person-group>. <year>2014</year>. <article-title>The phosphopantetheinyl transferases: catalysis of a post-translational modification crucial for life</article-title>. <source>Nat Prod Rep</source>
<volume>31</volume>:<fpage>61</fpage>&#x02013;<lpage>108</lpage>. doi:<pub-id pub-id-type="doi">10.1039/c3np70054b</pub-id>.<pub-id pub-id-type="pmid">24292120</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ongley</surname>
<given-names>SE</given-names></string-name>, <string-name><surname>Bian</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Neilan</surname>
<given-names>BA</given-names></string-name>, <string-name><surname>M&#x000fc;ller</surname>
<given-names>R</given-names></string-name></person-group>. <year>2013</year>. <article-title>Recent advances in the heterologous expression of microbial natural product biosynthetic pathways</article-title>. <source>Nat Prod Rep</source>
<volume>30</volume>:<fpage>1121</fpage>&#x02013;<lpage>1138</lpage>. doi:<pub-id pub-id-type="doi">10.1039/c3np70034h</pub-id>.<pub-id pub-id-type="pmid">23832108</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xie</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Zeng</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Luo</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Pan</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Xie</surname>
<given-names>J</given-names></string-name></person-group>. <year>2014</year>. <article-title>The roles of bacterial GCN5-related N-acetyltransferases</article-title>. <source>Crit Rev Eukaryot Gene Expr</source>
<volume>24</volume>:<fpage>77</fpage>&#x02013;<lpage>87</lpage>. doi:<pub-id pub-id-type="doi">10.1615/critreveukaryotgeneexpr.2014007988</pub-id>.<pub-id pub-id-type="pmid">24579671</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Salah Ud-Din</surname>
<given-names>AIM</given-names></string-name>, <string-name><surname>Tikhomirova</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Roujeinikova</surname>
<given-names>A</given-names></string-name></person-group>. <year>2016</year>. <article-title>Structure and functional diversity of GCN5-related N-acetyltransferases (GNAT)</article-title>. <source>Int J Mol Sci</source>
<volume>17</volume>:<fpage>1018</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms17071018</pub-id>.</mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Favrot</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Blanchard</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Vergnolle</surname>
<given-names>O</given-names></string-name></person-group>. <year>2016</year>. <article-title>Bacterial GCN5-related N-acetyltransferases: from resistance to regulation</article-title>. <source>Biochemistry</source>
<volume>55</volume>:<fpage>989</fpage>&#x02013;<lpage>1002</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acs.biochem.5b01269</pub-id>.<pub-id pub-id-type="pmid">26818562</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Salian</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Matt</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Akbergenov</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Harish</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Meyer</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Duscha</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Shcherbakov</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Bernet</surname>
<given-names>BB</given-names></string-name>, <string-name><surname>Vasella</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Westhof</surname>
<given-names>E</given-names></string-name>, <string-name><surname>B&#x000f6;ttger</surname>
<given-names>EC</given-names></string-name></person-group>. <year>2012</year>. <article-title>Structure-activity relationships among the kanamycin aminoglycosides: role of ring I hydroxyl and amino groups</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>56</volume>:<fpage>6104</fpage>&#x02013;<lpage>6108</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.01326-12</pub-id>.<pub-id pub-id-type="pmid">22948879</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sarciaux</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Pantel</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Midrier</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Serri</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gerber</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Marcia de Figueiredo</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Campagne</surname>
<given-names>J-M</given-names></string-name>, <string-name><surname>Villain-Guillot</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Gualtieri</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Racine</surname>
<given-names>E</given-names></string-name></person-group>. <year>2018</year>. <article-title>Total synthesis and structure&#x02013;activity relationships study of odilorhabdins, a new class of peptides showing potent antibacterial activity</article-title>. <source>J Med Chem</source>
<volume>61</volume>:<fpage>7814</fpage>&#x02013;<lpage>7826</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acs.jmedchem.8b00790</pub-id>.<pub-id pub-id-type="pmid">30086230</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Desriac</surname>
<given-names>F</given-names></string-name>, <string-name><surname>El Harras</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Simon</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bondon</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Brillet</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Le Chevalier</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Pugni&#x000e8;re</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Got</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Destoumieux-Garz&#x000f3;n</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Fleury</surname>
<given-names>Y</given-names></string-name></person-group>. <year>2020</year>. <article-title>Alterins produced by oyster-associated Pseudoalteromonas are antibacterial cyclolipopeptides with LPS-binding activity</article-title>. <source>Marine Drugs</source>
<volume>18</volume>:<fpage>630</fpage>. doi:<pub-id pub-id-type="doi">10.3390/md18120630</pub-id>.</mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fischer-Le Saux</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Viallard</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Brunel</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Normand</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Boemare</surname>
<given-names>NE</given-names></string-name></person-group>. <year>1999</year>. <article-title>Polyphasic classification of the genus <italic toggle="yes">Photorhabdus</italic> and proposal of new taxa: <italic toggle="yes">P. luminescens</italic> subsp. <italic toggle="yes">luminescens</italic> subsp. nov., <italic toggle="yes">P. luminescens</italic> subsp. <italic toggle="yes">akhurstii</italic> subsp. nov., <italic toggle="yes">P. luminescens</italic> subsp. <italic toggle="yes">laumondii</italic> subsp. nov., <italic toggle="yes">P. temperata</italic> sp. nov., <italic toggle="yes">P. temperata</italic> subsp. <italic toggle="yes">temperata</italic> subsp. nov. and <italic toggle="yes">P. asymbiotica</italic> sp. nov</article-title>. <source>Int J Syst Bacteriol</source>
<volume>49</volume>:<fpage>1645</fpage>&#x02013;<lpage>1656</lpage>. doi:<pub-id pub-id-type="doi">10.1099/00207713-49-4-1645</pub-id>.<pub-id pub-id-type="pmid">10555346</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Machado</surname>
<given-names>RAR</given-names></string-name>, <string-name><surname>W&#x000fc;thrich</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Kuhnert</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Arce</surname>
<given-names>CCM</given-names></string-name>, <string-name><surname>Th&#x000f6;nen</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Ruiz</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Robert</surname>
<given-names>CAM</given-names></string-name>, <string-name><surname>Karimi</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kamali</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ma</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Bruggmann</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Erb</surname>
<given-names>M</given-names></string-name></person-group>. <year>2018</year>. <article-title>Whole-genome-based revisit of <italic toggle="yes">Photorhabdus</italic> phylogeny: proposal for the elevation of most <italic toggle="yes">Photorhabdus</italic> subspecies to the species level and description of one novel species <italic toggle="yes">Photorhabdus bodei</italic> sp. nov., and one novel subspecies <italic toggle="yes">Photorhabdus laumondii</italic> subsp. <italic toggle="yes">clarkei</italic> subsp. nov</article-title>. <source>Int J Syst Evol Microbiol</source>
<volume>68</volume>:<fpage>2664</fpage>&#x02013;<lpage>2681</lpage>. doi:<pub-id pub-id-type="doi">10.1099/ijsem.0.002820</pub-id>.<pub-id pub-id-type="pmid">29877789</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mougin</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Artige</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Marchand</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Mondy</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Rati&#x000e9;</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Sellier</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Castagnone-Sereno</surname>
<given-names>P</given-names></string-name>, <string-name><surname>D&#x02019;Acier</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>Esmenjaud</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Faivre-Primot</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Granjon</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Hamelet</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Lange</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Pag&#x000e8;s</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Rimet</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Ris</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Sall&#x000e9;</surname>
<given-names>G</given-names></string-name></person-group>. <year>2018</year>. <article-title>BRC4Env, a network of biological resource centres for research in environmental and agricultural sciences</article-title>. <source>Environ Sci Pollut Res Int</source>
<volume>25</volume>:<fpage>33849</fpage>&#x02013;<lpage>33857</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11356-018-1973-7</pub-id>.<pub-id pub-id-type="pmid">29675816</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ogier</surname>
<given-names>J-C</given-names></string-name>, <string-name><surname>Calteau</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Forst</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Goodrich-Blair</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Roche</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Rouy</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Suen</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Zumbihl</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Givaudan</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Tailliez</surname>
<given-names>P</given-names></string-name>, <string-name><surname>M&#x000e9;digue</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Gaudriault</surname>
<given-names>S</given-names></string-name></person-group>. <year>2010</year>. <article-title>Units of plasticity in bacterial genomes: new insight from the comparative genomics of two bacteria interacting with invertebrates, <italic toggle="yes">Photorhabdus</italic> and <italic toggle="yes">Xenorhabdus</italic></article-title>. <source>BMC Genomics</source>
<volume>11</volume>:<fpage>568</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1471-2164-11-568</pub-id>.<pub-id pub-id-type="pmid">20950463</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nielsen-LeRoux</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Gaudriault</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ramarao</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Lereclus</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Givaudan</surname>
<given-names>A</given-names></string-name></person-group>. <year>2012</year>. <article-title>How the insect pathogen bacteria <italic toggle="yes">Bacillus thuringiensis</italic> and <italic toggle="yes">Xenorhabdus/Photorhabdus</italic> occupy their hosts</article-title>. <source>Curr Opin Microbiol</source>
<volume>15</volume>:<fpage>220</fpage>&#x02013;<lpage>231</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mib.2012.04.006</pub-id>.<pub-id pub-id-type="pmid">22633889</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Benveniste</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Davies</surname>
<given-names>J</given-names></string-name></person-group>. <year>1973</year>. <article-title>Aminoglycoside antibiotic-inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>70</volume>:<fpage>2276</fpage>&#x02013;<lpage>2280</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.70.8.2276</pub-id>.<pub-id pub-id-type="pmid">4209515</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Ausubel</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Brent</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Kingston</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Moore</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Seidma</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Struhl</surname>
<given-names>K</given-names></string-name></person-group>. <year>1988</year>. <source>Current protocols in molecular biology</source>. <publisher-name>John Wiley &#x00026; Sons, Inc</publisher-name>, <publisher-loc>New York NY</publisher-loc>.</mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mouammine</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Pages</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Lanois</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Gaudriault</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Jubelin</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Bonabaud</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Cruveiller</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Dubois</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Roche</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Legrand</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Brillard</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Givaudan</surname>
<given-names>A</given-names></string-name></person-group>. <year>2017</year>. <article-title>An antimicrobial peptide-resistant minor subpopulation of <italic toggle="yes">Photorhabdus luminescens</italic> is responsible for virulence</article-title>. <source>Sci Rep</source>
<volume>7</volume>:<fpage>43670</fpage>. doi:<pub-id pub-id-type="doi">10.1038/srep43670</pub-id>.<pub-id pub-id-type="pmid">28252016</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Srikhanta</surname>
<given-names>YN</given-names></string-name>, <string-name><surname>Dowideit</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>Edwards</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Falsetta</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>Harrison</surname>
<given-names>OB</given-names></string-name>, <string-name><surname>Fox</surname>
<given-names>KL</given-names></string-name>, <string-name><surname>Seib</surname>
<given-names>KL</given-names></string-name>, <string-name><surname>Maguire</surname>
<given-names>TL</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>AHJ</given-names></string-name>, <string-name><surname>Maiden</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Grimmond</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Apicella</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Jennings</surname>
<given-names>MP</given-names></string-name></person-group>. <year>2009</year>. <article-title>Phasevarions mediate random switching of gene expression in pathogenic <italic toggle="yes">Neisseria</italic></article-title>. <source>PLoS Pathog</source>
<volume>5</volume>:<elocation-id>e1000400</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1000400</pub-id>.<pub-id pub-id-type="pmid">19390608</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jubelin</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Lanois</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Severac</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Rialle</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Longin</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Gaudriault</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Givaudan</surname>
<given-names>A</given-names></string-name></person-group>. <year>2013</year>. <article-title>FliZ is a global regulatory protein affecting the expression of flagellar and virulence genes in individual <italic toggle="yes">Xenorhabdus nematophila</italic> bacterial cells</article-title>. <source>PLoS Genet</source>
<volume>9</volume>:<elocation-id>e1003915</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pgen.1003915</pub-id>.<pub-id pub-id-type="pmid">24204316</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="book"><collab>Clinical and Laboratory Standards Institute</collab>. <year>2015</year>. <source>Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. CLSI document M07-A10</source>, <edition>10th ed</edition>. <publisher-name>Clinical and Laboratory Standards Institute</publisher-name>, <publisher-loc>Wayne, PA</publisher-loc>.</mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ondov</surname>
<given-names>BD</given-names></string-name>, <string-name><surname>Treangen</surname>
<given-names>TJ</given-names></string-name>, <string-name><surname>Melsted</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Mallonee</surname>
<given-names>AB</given-names></string-name>, <string-name><surname>Bergman</surname>
<given-names>NH</given-names></string-name>, <string-name><surname>Koren</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Phillippy</surname>
<given-names>AM</given-names></string-name></person-group>. <year>2016</year>. <article-title>Mash: fast genome and metagenome distance estimation using MinHash</article-title>. <source>Genome Biol</source>
<volume>17</volume>:<fpage>132</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13059-016-0997-x</pub-id>.<pub-id pub-id-type="pmid">27323842</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gouy</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Guindon</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Gascuel</surname>
<given-names>O</given-names></string-name></person-group>. <year>2010</year>. <article-title>SeaView Version 4: a multiplatform graphical user interface for sequence alignment and phylogenetic tree building</article-title>. <source>Mol Biol Evol</source>
<volume>27</volume>:<fpage>221</fpage>&#x02013;<lpage>224</lpage>. doi:<pub-id pub-id-type="doi">10.1093/molbev/msp259</pub-id>.<pub-id pub-id-type="pmid">19854763</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jones</surname>
<given-names>DT</given-names></string-name>, <string-name><surname>Taylor</surname>
<given-names>WR</given-names></string-name>, <string-name><surname>Thornton</surname>
<given-names>JM</given-names></string-name></person-group>. <year>1992</year>. <article-title>The rapid generation of mutation data matrices from protein sequences</article-title>. <source>Comput Appl Biosci</source>
<volume>8</volume>:<fpage>275</fpage>&#x02013;<lpage>282</lpage>. doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/8.3.275</pub-id>.<pub-id pub-id-type="pmid">1633570</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kumar</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Stecher</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Tamura</surname>
<given-names>K</given-names></string-name></person-group>. <year>2016</year>. <article-title>MEGA7: Molecular Evolutionary Genetics Analysis version 7.0 for bigger datasets</article-title>. <source>Mol Biol Evol</source>
<volume>33</volume>:<fpage>1870</fpage>&#x02013;<lpage>1874</lpage>. doi:<pub-id pub-id-type="doi">10.1093/molbev/msw054</pub-id>.<pub-id pub-id-type="pmid">27004904</pub-id></mixed-citation></ref></ref-list></back></article>